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ABSTRACT 
Introduction: Staphylococcus aureus is a versatile pathogen that produces multiple virulence factors which 
work together to establish and maintain infections. The accessory gene regulator (agr) locus is a quorum 
sensing two-component system which regulates at least 23 virulence factors. There are four different agr types, 
I-IV, and mutations within the agr locus may result in a dysfunctional agr. These can result in altered gene 
expression which may affect disease presentation and outcome. Data on the molecular epidemiology of S. 
aureus and its association with clinical outcome in South Africa is limited. This study aimed to determine the 
effect of epidemiology and agr-associated virulence characteristics on the clinical outcome of bacteraemic 
patients at Tygerberg Hospital. 
Methods: S. aureus isolates were collected from blood cultures from February 2015 to March 2017. 
Genotyping was performed using staphylococcal protein A (spa) typing and multi-locus sequence typing 
(MLST); and staphylococcal cassette chromosome mec (SCCmec) typing was performed on all methicillin 
resistant S. aureus (MRSA) isolates. Agr typing was performed by PCR and agr functionality was assessed 
using a phenotypic δ-haemolysin assay and matrix assisted laser desorption ionisation-time of flight mass 
spectrometry (MALDI-TOF MS). Associations between patient- and strain- characteristics, and the final 
outcomes mortality, methicillin resistance and length of stay were investigated by means of regression models. 
Results and discussion: Of the 199 S. aureus isolates collected, 27% were MRSA. Seventy three spa types 
were identified; reflecting a diverse population. MRSA isolates were more clonal than methicillin susceptible 
S. aureus (MSSA) isolates. A previously described novel variant SCCmec type (NV) and SCCmec type IV 
were most common among MRSA isolates. Agr type I was the dominant agr type, while agr type IV was least 
prevalent; consistent with the literature. The dominant clone in this study was an MRSA outbreak strain, t045-
ST5-MRSA-NV, agr type II (spa-CC 002, CC5), which appears to be circulating in multiple hospital settings in 
South Africa. The most prevalent MSSA strain/clone was t318-ST1865, agr type III. Pandemic clones such as 
t037-ST239-MRSA-III, t032-ST22-MRSA-IV and t012-ST36-MRSA-II were also identified. A previously 
described association between MRSA and spa-CC 002 (CC5) was confirmed in this study; however this 
association may have been driven by the MRSA outbreak. Agr dysfunctionality was low at 12.6% and 6% using 
the phenotypic assay and MALDI-TOF MS respectively. Agr dysfunctionality was not clone specific and there 
was no difference in agr dysfunctionality between MRSA and MSSA isolates. A borderline association between 
agr dysfunction and shorter length of stay was identified, but needs further investigation. The overall mortality 
rate was 29% and older age was associated with increased mortality. Hospital acquired (HA) infections were 
also associated with a higher mortality, which could be explained by the complicated nature of these infections, 
leading to death. An association between HA infections and MRSA was identified, which is consistent with 
previous studies and not surprising considering antibiotic selective pressure is higher in hospitals. 
Conclusion: This study provides insights into the associations between S. aureus epidemiology and agr 
related virulence characteristics and clinical outcome, despite the limited clinical data available.  
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OPSOMMING 
Inleiding: Staphylococcus aureus is 'n veelsydige patogeen wat verskeie virulensie-faktore produseer wat 
saamwerk om infeksies te veroorsaak en onderhou. Die geassosieerde geen reguleerder (agr) lokus is 'n 
dubbele-komponent kworumwaarnemingstelsel wat minstens 23 virulensie-faktore reguleer. Daar is vier 
verskillende agr tipes, I-IV. Mutasies in die agr lokus lei dikwels tot ‘n disfunksionele agr wat daaropvolgend 
lei tot wisselende geen uitdrukking, wat die voorkoms en uitkoms van siektes kan beïnvloed. Data oor die 
molekulêre epidemiologie van S. aureus en die assosiasie daarvan met kliniese uitkoms in Suid-Afrika is 
beperk. Hierdie studie het gepoog om die effek van epidemiologiese- en agr-verwante virulensie eienskappe 
op die kliniese uitkoms van pasiënte met bakteremie by Tygerberg Hospitaal te bepaal. 
Metodes: S. aureus isolate van bloedkulture was vanaf Februarie 2015 tot Maart 2017 versamel. Genotipering 
was uitgevoer met behulp van stafilokokkale proteïn A (spa) tipering en multi-lokus volgordebepaling (MLST). 
“Staphylococcal chromosome complex mec” (SCCmec) tipering was op alle metisillienweerstandige 
Staphylococcus aureus (MRSA) isolate uitgevoer. Agr tipering was deur polimerasekettingreaksie (PKR) 
uitgevoer en agr funksionaliteit was met behulp van 'n fenotipiese δ-hemolisien toets en “matrix assisted laser 
desorption ionisation-time of flight mass spectrometry” (MALDI-TOF MS) ondersoek. Assosiasies tussen 
pasiënt- en stam-eienskappe met die finale uitkomstes, mortaliteit, metisillienweerstandigheid en lengte van 
hospitaalverblyf, was ondersoek. 
Resultate en bespreking: Sewe-en-twintig persent van die 199 S. aureus-isolate wat ingesamel is, was 
metisillienweerstandig. Drie-en-sewentig spa-tipes is geïdentifiseer; wat 'n diverse bevolking weerspieël. 
MRSA-isolate was meer klonaal as metisillien-vatbare S. aureus (MSSA) isolate. 'n Nuwe variant SCCmec-
tipe (NV), voorheen beskryf, en SCCmec-tipe IV was die algemeenste tipe in die MRSA groep. Agr tipe I was 
die dominante agr tipe, terwyl agr tipe IV die minste voorgekom het; dit stem ooreen met wat in literatuur 
beskryf word. Die dominante kloon in hierdie studie was 'n MRSA-uitbraakstam, t045-ST5-MRSA-NV, agr tipe 
II (spa-CC 002, CC5), wat in verskeie hospitale in Suid-Afrika voorkom. Die algemeenste MSSA kloon was 
t318-ST1865, agr tipe III. Pandemiese klone soos t037-ST239-MRSA-III, t032-ST22-MRSA-IV en t012-ST36-
MRSA-II is ook geïdentifiseer. 'n Voorheen beskryfde assosiasie tussen MRSA en spa-CC 002 (CC5) is in 
hierdie studie bevestig; dit is egter moontlik dat dit deur die MRSA-uitbraak gedryf kon word. Agr disfunksie 
was laag, 12.6% en 6%, soos bepaal deur die fenotipiese δ-hemolisien toets en MALDI-TOF MS 
onderskeidelik. Agr disfunksionaliteit was nie kloon spesifiek nie en daar was geen verskil in agr 
disfunksionaliteit tussen MRSA en MSSA isolate nie. Die assosiasie tussen agr disfunksie en ‘n korter 
hospitaalverblyf het gegrens aan statistiese betekenisvolheid, maar dit benodig verdere ondersoek. Die totale 
sterftesyfer was 29% en ouer ouderdom is geassosieer met verhoogde sterftes. Hospitaalverworwe (HA) 
infeksies is ook geassosieer met 'n hoër sterftesyfer, wat verklaar kan word deur die ingewikkelde aard van 
hierdie infeksies wat tot die dood lei. 'n Assosiasie tussen HA-infeksies en MRSA is geïdentifiseer; dit stem 
ooreen met vorige studies en is nie verbasend nie, aangesien antibiotika-selektiewe-druk in hospitale hoër is. 
Gevolgtrekking: Hierdie studie bied insig oor die assosiasies tussen S. aureus epidemiologie en agr-verwante 
virulensie eienskappe en kliniese uitkoms, ten spyte van die beperkte kliniese data wat beskikbaar was. 
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 Literature review 
Staphylococcus aureus 
Staphylococcus aureus is a Gram positive, non-motile, coccus shaped bacterium, which often forms 
clusters. S. aureus is an extremely versatile pathogen, responsible for a wide range of superficial 
infections (e.g. wound infections), deep-seated infections (e.g. pneumonia) and toxaemic syndromes 
such as staphylococcal scarlet fever and toxic shock syndrome (Ben Ayed et al., 2008).  
Asymptomatic colonization of the nasopharynx, perineum or skin of human hosts, by S. aureus, is 
far more common than infection and often occurs shortly after birth and may re-occur at any time 
thereafter (Chambers, 2001). S. aureus is transferred by direct contact and therefore family 
members and contacts of colonised individuals may become colonised. Colonization may be 
transient or persistent and may last for years (Chambers, 2001). S. aureus carriage rates are 
between 25% and 50%, with higher rates observed in injection drug users, individuals with insulin-
independent diabetes, health care workers, patients with dermatologic conditions, as well as patients 
with long-term indwelling intravascular catheters. Children tend to have higher colonization rates 
than adults because of their repeated person-to-person interaction and their recurrent contact with 
respiratory secretions (Adcock et al., 1998). 
S. aureus is a frequent hospital-acquired (HA) pathogen that is commonly isolated from blood 
cultures. Before antibiotics were available for the treatment of S. aureus bacteraemia the mortality 
rate was as high as 82%-98% and the introduction of penicillin in the early 1940’s had a great impact 
on treatment outcome (Stefani et al., 2012). In 1959, methicillin was introduced to overcome 
problems caused by strains resistant to penicillin G and penicillin V (Enright et al., 2000). However, 
methicillin resistant S. aureus (MRSA) strains quickly developed, causing the fatality rate to remain 
high (15-50%) and resulting in major problems for hospitals world-wide (Speller et al., 1997; Perovic 
et al., 2015). The first methicillin resistant strain was reported in 1961 in the United Kingdom and 
MRSA strains were soon reported in European countries followed by Japan, Australia and the United 
States. MRSA is now a worldwide problem and is increasingly isolated from hospitals and the 
community (Voss and Doebbeling, 1995; Green et al., 2012; Earls et al., 2017). Methicillin resistance 
is acquired by the insertion of the staphylococcal cassette chromosome mec (SCCmec) element into 
the chromosome of antibiotic susceptible strains (Hiramatsu et al., 2001). The SCCmec element 
carries the gene responsible for resistance, namely mecA, encoding for a methicillin-resistant 
penicillin-binding protein that is absent in methicillin susceptible strains (Enright et al., 2002). 
Although the SCCmec element is widely dispersed and exclusively found in staphylococci, the exact 
origin of the element is unknown (Hiramatsu et al., 2001). 
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Infections can be classified as hospital acquired (HA), health care associated (HCA) or community 
acquired (CA), depending on the source of the infection. HA-MRSA and HCA-MRSA isolates are 
often isolated from immunocompromised patients and are resistant to multiple antimicrobials, while 
CA-MRSA isolates used to be associated with colonization and were usually susceptible to other 
antimicrobials (Earls et al., 2017). These distinctions between the groups have however become 
blurred (Earls et al., 2017). Recent studies have shown that MRSA strains from multiple different 
clinical sources are often resistant to many other classes of antibiotics and show decreased 
susceptibility to glycopeptides, which threatens the ability to treat infections caused by MRSA strains 
(Enright et al., 2000; Earls et al., 2017). 
Molecular epidemiology of Staphylococcus aureus 
Strain typing methods  
Many epidemiological studies have used various strain typing methods to describe the distribution 
of different S. aureus strains within and between settings and to investigate the cross-border 
differences in molecular epidemiology at a global level (Stefani et al., 2012; Abdulgader et al., 2015). 
There are multiple different bacterial strain typing methods available, including phenotypic methods, 
such as serotyping, phage typing and antibiotic resistance profiles, and genotypic based methods. 
Appropriate strain typing technique should include the following (Stefani et al., 2012): 
• portable data, highly reproducible and unambiguous; 
• inter- and intra-laboratory compatibility; 
• low-cost methodology; 
• rapid throughput; 
• easy processing, storage and exchange/distribution of data; 
• standardised nomenclature recognised internationally; 
• quality control of ‘raw’ typing data (external quality control); 
• flexibility of use for a variety of microorganisms 
The methods which are frequently used for S. aureus strain typing include spa typing, pulsed field 
gel electrophoresis (PFGE), multilocus sequence typing (MLST), repetitive element palindromic PCR 
(rep-PCR), multilocus variable tandem repeat analysis (MLVA) and whole genome sequencing 
(WGS); as well as staphylococcal chromosomal cassette mec (SCCmec) typing for MRSA strains 
(Struelens et al., 2009). Although none of these strain typing methods meet all the requirements 
listed above; spa typing, MLST and SCCmec typing are generally preferred over PFGE and MLVA 
(Stefani et al., 2012). The reason for this may be that PFGE and MLVA have limited portability and 
no standard nomenclature. Table 1.1 describes the strengths and limitations of strain typing methods 
used for S. aureus. 
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Table 1.1: Features of frequently used S. aureus strain typing methods. (Adapted from Ross et al., 2005; 
Struelens et al., 2009; Stefani et al., 2012). 
Method Principle Strengths Limitations 
spa typing Amplification and 
sequencing of the 
hypervariable X region of 
the spa gene for S. aureus 
surface protein A 
Rapid, standard 
nomenclature, portable, 
high throughput 
Misclassification of a 
small number of 
lineages because of 
homoplasy 
PFGE Restriction polymorphisms 
of the whole genome 
High discriminatory 
index 
Laborious, slow, limited 
portability, 
misclassification of 
some lineages, multiple 
nomenclatures 
MLST Core genetic population 
(amplification and 
sequencing of seven 
housekeeping genes) 
Defines core genetic 
population, standard 
nomenclature, portable 
Low throughput, high 
cost 
rep-PCR Amplification of the 
regions between the non-
coding repetitive 
sequences in the genome 
High discriminatory 
index, rapid 
poor inter-laboratory 
reproducibility, 
misclassification of 
some lineages, no 
standard nomenclature 
MLVA Polymorphisms in 
chromosomal VNTR 
elements 
High throughput, rapid No standard protocol or 
nomenclature, 
misclassification of 
some lineages 
WGS Sequencing of the entire 
genome 
Reproducible, high 
discriminatory index 
Expensive, complex 
sample preparation, 
interpretation of results 
is difficult 
SCCmec 
typing 
MGEs Standard nomenclature Low throughput, high 
cost, evolving 
nomenclature 
*variable number tandem repeat (VNTR), mobile genetic elements (MGEs) 
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spa typing 
spa typing involves PCR amplification and determination of the sequence polymorphisms in the 
hypervariable region of the spa gene, specifically the polymorphic X region; and is currently one of 
the most popular S. aureus typing methods (Hallin et al., 2009; Struelens et al., 2009). The spa gene 
encodes protein A, which is a cell-wall component that is bound by its carboxy-terminal to the 
peptidoglycan of S. aureus (Hallin et al., 2009). The N-terminal of the spa gene encodes four to five 
binding units for immunoglobulin G (IgG), while the X region is on the C-terminal and displays a 
variable number of short repeat units (24bp) flanked by well-conserved regions (Hallin et al., 2009). 
Figure 1.1 features the C-terminal, which is divided into two regions; the constant Xc region that 
encodes for cell-wall attachment and the hypervariable Xr region that displays the variable number 
tandem repeats (VNTR). The Xr region is amplified during spa typing and the strain type is 
characterised based on the VNTR succession (Hallin et al., 2009). The nomenclature for this method 
is as follows: for each new base composition within the polymorphic region the strain is assigned a 
unique repeat code and each n-long repeat code corresponds to a repeat succession. A repeat 
succession is allocated to each strain, which determines the spa type of the strain. A “type” number 
preceded by a “t” is assigned to every repeat profile. (Source: Harmsen et al., 2003).  
Figure 1.1: The spa typing principle. a) Map of the spa gene. X represents the C-terminal and is divided into 
two regions; the constant Xc region encoding for cell-wall attachment and the hypervariable (VNTR) Xr region, 
which is amplified and used for spa typing. b) Xr region repeat structure. c) The DNA sequence of spa repeat 
21 (Ridom). (Source: Hallin et al., 2009). 
spa typing has many practical advantages which may be the reason for its popularity. These 
advantages include high throughput, reproducibility and portability of data; and isolates are assigned 
spa types through the internet, which enables access to an international database and allows 
comparison on a worldwide scale (Struelens et al., 2009). The Ridom spa typing server 
(https://www.spaserver.ridom.de) provides a standard universally recognized nomenclature as well 
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as integral quality control for spa typing. The Ridom StaphType software (Ridom GmbH, Germany) 
also allows related spa types to be clustered into clonal complexes (CCs) using the based upon 
repeat patterns (BURP) algorithm; these spa-CCs show good congruency with MLST-CCs. 
The combination of spa typing with the based upon repeat pattern (BURP) analysis provides a strong 
epidemiological typing tool that is highly reproducible, and may be useful for both national and 
international surveillance of S. aureus strains. However, this single-locus-based method should be 
accompanied by other typing methods as well as detection of other markers in parallel to spa typing. 
This may increase the cost and time of the analysis, therefore, these markers should be selected 
based on the questions in need of answering and results from the spa typing-BURP analysis 
(Strommenger et al., 2008). 
Pulsed field gel electrophoresis (PFGE) 
Pulsed field gel electrophoresis (PFGE) involves the genomic macrorestriction of fragments 
separated by pulsed-field gel electrophoresis and has been used for outbreak investigation as well 
as surveillance at national and regional levels (Struelens et al., 2009). PFGE is highly discriminatory 
and many studies have been published with validated interpretation criteria and harmonised 
protocols for the investigation of regional transmission and outbreak investigation (Blanc et al., 2001; 
Murchan et al., 2003). Yet, it is a laborious and low-throughput method and multiple technical 
difficulties in achieving inter-laboratory comparability and standardization have been identified, 
resulting in limited portability (Struelens et al., 2009). Furthermore, some strains (such as ST398) 
are un-typeable because of restriction site methylation (Struelens et al., 2009). 
Multi-locus sequence typing (MLST) 
Multi-locus sequence typing (MLST) characterizes strains based on the sequences of approximately 
450 base pairs (bp) of internal fragments of seven housekeeping genes (arc, aroE, glpF, gmk, pta, 
tpi, yqiL). An allele number is assigned to the sequences of each of the seven gene fragments, and 
each combination of allele numbers represents a unique sequence type (ST) (Enright et al., 2000). 
STs are then grouped into clonal complexes (CCs) based on the similarity of their allelic profiles. 
MLST is highly discriminatory, the typing results are easily comparable between laboratories, and 
the ability to compare results on the internet is a major advantage (Enright et al., 2002). However, 
for epidemiological typing, MLST remains too labour intensive and expensive to use as the primary 
strain typing tool (Struelens et al., 2009). 
Other strain typing methods 
Other high throughput typing methods such as rep-PCR and multilocus variable tandem repeat 
analysis (MLVA) also exist. Rep-PCR varies in terms of discriminatory power, but it has been shown 
to be poorly reproducible when using protocols that are not kit-based (Struelens et al., 2009). A study 
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performed by Ross et al. in 2005 compared rep-PCR to PFGE for outbreak investigation. A kit-based 
rep-PCR assay (by Diversilab, Houston, TX, USA) showed outstanding reproducibility but moderate 
discriminatory power in comparison to PFGE. An advantage to rep-PCR is it’s low running cost 
(assuming the lab has the necessary equipment), ease of use and real time results, however 
interpretation guidelines and standard nomenclature are still lacking (Ross et al., 2005). MLVA, like 
rep-PCR, has a rapid turnaround time, high throughput, and variable discriminatory power however, 
to our knowledge, no international nomenclature or standard protocol is available (Stefani et al., 
2012). 
Lastly, whole genome sequencing (WGS), including single nucleotide polymorphism (SNP) analysis, 
is an alternative to the typing techniques mentioned above. WGS is becoming the gold standard 
because of its high discrimination compared to the above mentioned molecular typing methods, but 
it is too expensive to use as a primary typing tool (Earls et al., 2017). It is however over time 
becoming more available and affordable. The typing techniques discussed allow the identification of 
multiple S. aureus strains and CCs and as additional sequence variants are identified in these S. 
aureus strains a standard hierarchical SNP catalogue can be developed and used for high 
throughput SNP typing (Struelens et al., 2009). 
High concordance between spa typing and PFGE has been reported (Hallin et al. 2007). The majority 
of the inconsistencies were found in MLST CC8 and CC5, in which a number of MRSA isolates 
appeared to be sporadic by PFGE, but were shown to be more clonal by spa typing (t008/CC8 and 
t002/CC5). This may be due to the nature of the typing methods; spa typing being a single locus and 
PFGE being a whole genome typing method and has a higher discriminatory power than spa typing. 
Genetic events such as insertions and/or deletions of mobile genetic elements which occur across 
the genome may result in diverse PFGE patterns, while the targets for spa typing and MLST remain 
unaffected. It has been concluded that spa typing can be used for the same purposes as PFGE, 
however, additional typing schemes should be used for resistant strains such as SCCmec typing or 
further investigating markers such as resistance or virulence genes; especially in rapidly evolving 
strains (such as strains from spa-CC5 and spa-CC8) (Hallin et al., 2007). It is now common to define 
clones by the combination of their chromosomal background by different typing methods, for 
example spa type in combination with MLST ST (such as t00x-STy) and in the case of MRSA 
isolates, the SCCmec type is added (such as t00x-STy-MRSA-z). 
Staphylococcal chromosomal cassette mec typing (SCCmec typing) 
The SCCmec element is a mobile genetic element composed of the mec gene complex encoding 
methicillin resistance and the ccr gene complex encoding recombinases responsible for the mobility 
of the element (Hiramatsu et al., 2001). SCCmec elements have been grouped into thirteen types 
defined by the combination of mec and ccr gene complex types (Table 1.2) (Ito et al., 2009; Martínez-
Meléndez et al., 2015; Baig et al., 2018). SCCmec typing can assist with surveillance of transmission 
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and evolution of MRSA strains between hospitals and even internationally (Struelens et al., 2009). 
There are several methods available for typing and subtyping of MRSA, either by PCR mapping of 
the cassette elements or by sequence determination of ccrB (Struelens et al., 2009). A combination 
of these two methods is recommended for reliable MRSA typing. 
Table 1.2: Currently identified SCCmec types. (Adapted from Ito et al., 2009; Martínez-Meléndez et al., 
2015; Baig et al., 2018). 
SCCmec type ccr gene complex mec gene complex 
I 1 (A1B1) B 
II 2 (A2B2) A 
III 3 (A3B3) A 
IV 2 (A2B2) B 
V 5 (C1) C2 
VI 4 (A4B4) B 
VII 5 (C1) C1 
VIII 4 (A4B4) A 
IX 1 (A1B1) C2 
X 7 (A1B6) C1 
XI 8(A1B3) E 
XII 9 (C2) C2 
XIII 9 (C2) A 
 
The mec gene complex consists of the mecA gene which encodes a methicillin-resistant penicillin-
binding protein, mecA regulatory genes (mecR1 and mecI), as well as associated insertion 
sequences (IS) (Figure 1.2). There are five different mec classes, classes A-E (Table 1.3). Class A 
mec is the prototype complex and consists of mecA, the regulatory genes (complete mecR1 and 
mecI) upstream of mecA, the hypervariable region (HVR) and the insertion sequence IS431 
downstream of mecA (Katayama et al., 2001). The class B mec gene complex contains the mecA 
gene and a truncated mecR1 (ΔmecR1) (as a result of IS1272) upstream of the mecA while the HVR 
and IS431 insertion sequence are downstream of mecA (Ito et al., 2009). The class C mec gene 
complex contains mecA and ΔmecR1 (as a result of IS431) upstream of mecA; another IS431 
insertion sequence and HVR are present downstream of mecA (Ito et al., 2009). There are two 
different class C mec gene complexes; in the first (class C1 mec gene complex), the two IS431 
insertion sequences upstream and downstream of mecA have the same orientation, while in the 
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second (class C2 mec gene complex), the orientation of IS431 upstream of mecA is reversed 
(Katayama et al., 2001). The two class C2 mec complexes are likely to have evolved independently 
and are therefore regarded as two different mec complexes. The class D mec gene complex contains 
mecA, ΔmecR1 and no insertion sequence downstream of ΔmecR1 (Ito et al., 2009). Class E is 
similar to class D, but contains a greater degree of deletion in ΔmecR1 (Martínez-Meléndez et al., 
2015). Variants within the major classes have been identified and described; these include insertions 
of IS431 and/or IS1182 upstream of the mec gene in the class A mec gene complex as well as 
insertion of Tn4001 upstream of the mecA gene in the class B mec gene complex. These variants 
have been designated a number following the class for example the class B mec gene complex 
variant is called the class B2 mec gene complex (Ito et al., 2009). 
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Figure 1.2: The basic structure of the SCCmec elements of SCCmec types I-XIII. (Source: Baig et al., 
2018).  
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Table 1.3: Structure of mec classes A-E. (Adapted from Martines-Malendez et al., 2015). 
mec class mec structure 
A mecI–mecR1–mecA–IS431 
B IS1272–ΔmecR1–mecA–IS431 
C IS431–ΔmecR1–mecA–IS431 
D ΔmecR1–mecA–IS431 
E ΔmecR1–mecA–IS431 
 
The ccr gene complex consists of a combination of three ccr gene types identified in S. aureus, 
namely ccrA, ccrB and ccrC, and the surrounding open reading frames (ORFs). The three different 
ccr genes have DNA sequence similarities of less than 50% and four allotypes have been identified 
for the ccrA and ccrB genes (Ito et al., 2009). There is only one ccrC allotype since all of the ccrC 
genes share greater than 87% similarity (Figure 1.3) (Ito et al., 2009). 
Figure 1.3: Schematic representation of the ccr genes, the DNA sequence similarity between them and 
the different allotypes present within each ccr gene type. (Source: Ito et al., 2009). 
Epidemiology of Staphylococcus aureus 
The majority (88%) of MSSA isolates have been shown to cluster into eleven MLST CCs, namely 
CC1, CC5, CC8, CC9, CC12, CC15, CC22, CC25, CC30, CC45, and CC51/121, with CC30 being 
the dominant MSSA CC (Enright et al., 2000, 2002; Hallin et al., 2007; Chambers and DeLeo, 2009; 
Breurec et al., 2011). MRSA, however, has been shown to be more clonal. Five major CCs, namely 
CC5, CC8, CC22, CC30 and CC45, have been defined as the dominant clones among HA-MRSA 
isolates from all continents (Stefani et al., 2012). CC8 and CC30 are pandemic lineages and are, 
together with CC1 and CC80, also associated with CA-MRSA (Abdulgader et al., 2015).  
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Regional clones have also been described in many countries or regions, and include ST93  in 
Australia (Chua et al., 2011), ST612 in South Africa and Australia (Moodley et al., 2010), ST72 in 
South Korea (Kim et al., 2014), ST88 in Africa and Asia (Otto and Chatterjee, 2013) and ST772 in 
India (Shambat et al., 2012). 
In Africa STs from CC5 have been shown to be most prevalent among MRSA isolates and ST239 
(Brazillian/Hungarian clone) has been described in nine African countries (Abdulgader et al., 2015). 
ST22-MRSA-IV, ST612-IV and ST36-MRSA-II were limited to South Africa (Moodley et al., 2010; 
Jansen van Rensburg et al., 2011; Oosthuysen et al., 2013), while the European clone ST80-MRSA-
IV was only reported in North African countries; Algeria, Egypt and Tunisia (Ramdani-bouguessa et 
al., 2006; Enany et al., 2010; Abdulgader et al., 2015). CA-MRSA clones ST8 and ST88 have also 
frequently been reported in Africa (Abdulgader et al., 2015). 
Epidemiology of Staphylococcus aureus in South Africa  
The epidemiology of S. aureus in South Africa has been investigated in six studies, in four provinces, 
between 2001 and 2012 (Table 1.4).  
Two studies described the epidemiology of S. aureus from multiple clinical sources in KwaZulu-Natal 
between January 2001 and August 2003. ST239 and ST5 were among the MRSA clones detected 
in both studies. Specifically, the MRSA clones circulating in 16 hospitals during January 2001 and 
December 2002 were ST8-MRSA-IV, ST239-MRSA-III, ST8-MRSA-II, ST5-MRSA-IV and ST45-
MRSA-IV (Essa et al., 2009). While, MRSA strain types t064-ST1173-MRSA-IV, t064-ST1338-
MRSA-IV, t037-ST239-MRSA-III and t045-ST5-MRSA-III were dominant in 13 health-care 
institutions during March 2001 to August 2003 (Shittu et al., 2009). The difference in strain types 
between the two studies may be attributed to the geographical origin of the samples and the fact 
that the samples were obtained from different clinical specimens, however this was not elaborated 
on in these studies. Only one of the two studies investigated both MSSA and MRSA isolates and 
reported MSSA strains to be more diverse compared to the MRSA strains, with ST1, ST5, ST8, ST9 
and ST88 being the dominant STs among the MSSA isolates (Essa et al., 2009). Despite the 
differences in clones detected in the two studies, SCCmec type IV was the most prevalent SCCmec 
type among MRSA isolates in both studies. This may be due to the fact that SCCmec type IV is a 
smaller and potentially more mobile SCCmec type compared to other SCCmec types. 
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Table 1.4: Distribution of S. aureus strain types in South Africa. 
Province Collection 
period 
Clinical 
source 
spa type spa-CC MLST ST MLST CC SCCmec 
type 
agr type Reference 
KwaZulu-
Natal 
2001-2002 Skin & soft 
tissue, otitis 
media, surgical 
site, 
septicaemia, 
other 
- - ST8, ST239, 
ST5, ST45, 
ST1, ST9, 
ST22, ST30, 
ST88 
- IV, III, II - Essa et al., 
2009 
KwaZulu-
Natal 
2001-2003 Wound, 
sputum, otitis 
media, blood, 
urine, eye, 
endotracheal 
aspirate 
t064, t037, 
t045 
- ST1173, 
ST1338, 
ST239, ST5 
- IV, III, IIIa, 
II, IIIb, I 
- Shittu et al., 
2009 
Western 
Cape 
2007-2008 Pus, pus 
swabs, 
respiratory 
tract 
specimens, 
urine, central 
venous 
catheter tips, 
blood 
t045, t037, 
t1443, 
t2196, 
t1143, t012, 
t064 
- ST612, ST5, 
ST239 
CC8, CC5 IV, I, II, III - Jansen van 
Rensburg et 
al., 2011 
Western 
Cape 
2008-2009 Blood cultures t037, t891, 
t1257, t002, 
t015, t021 
CC012, 
CC701, 
CC002, 
CC015 
ST239, ST612 CC8, CC30, 
CC45, CC5 
IV, III, II, V - Orth et al., 
2013 
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Province Collection 
period 
Clinical 
source 
spa type spa-CC MLST ST MLST CC SCCmec 
type 
agr type Reference 
Western 
Cape 
2009-2010 Skin & soft 
tissue, bone & 
joint, 
respiratory 
tract, 
prosthetic 
device, eye, 
urinary tract, 
unknown, 
other 
t891 CC891, 
CC021, 
CC015, 
CC064 
ST22, 
ST1865, 
ST45, ST36, 
ST612, ST8, 
ST1862, 
ST239 
CC22, 
CC30, CC8, 
CC45, CC5, 
CC15 
IV, I, II, III, 
V 
I, III, II, IV Oosthuysen 
et al., 2013 
Gauteng, 
Western 
Cape, Free 
State, 
KwaZulu-
Natal 
2010-2012 Blood cultures t037, t1257, 
t045, t064, 
t012 
CC064, 
CC037/012, 
CC045 
ST239,ST612, 
ST5, ST36 
CC8, CC5, 
CC30 
III, IV - Perovic et 
al., 2015 
*spa (staphylococcal protein A), CC (clonal complex), MLST (multi-locus sequence type), ST (sequence types), SCCmec (staphylococcal cassette 
chromosome mec), agr (accessory gene regulator).  
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Three studies described the epidemiology of S. aureus in the Western Cape between 2007 and 
2010; two studies were performed on isolates from Tygerberg Hospital while the other investigated 
isolates from five hospitals in Cape Town. ST239 and ST612 were present in all three these studies. 
Among isolates collected from January 2007 to December 2008 from five hospitals in the Cape Town 
(Western Cape), the dominant SCCmec type among the isolates was SCCmec type IV followed by 
I, II, III. Four clones were identified and accounted for 92% of the isolates, namely, ST612-MRSA-IV 
(multiple spa types including t064, t1443, t1257 and t2196), t045-ST5-MRSA-I, t012/t021-ST34-
MRSA-II and t037-ST239-MRSA-III. ST612 has infrequently been reported in South Africa and 
Australia, which suggests that it is an old local clone that has undergone clonal expansion over time. 
t002-ST650-MRSA-IV, t032-ST22-MRSA-IV and t3092-ST72-MRSA-NT were among the PFGE 
sporadic isolates (Jansen van Rensburg et al., 2011). Furthermore, at Tygerberg Hospital, Cape 
Town (Western Cape), 113 isolates were collected from blood cultures from April 2008 to May 2009 
and 30% were MRSA isolates (Orth et al., 2013). The dominant spa types were t037 and t891, and 
all the spa types clustered into four major spa-CCs (spa-CC701, spa-CC012, spa-CC002, spa-
CC015). Majority of the MRSA isolates clustered into spa-CC012 (53%) and spa-CC701 (43%), 
while MSSA strains showed more diversity, spanning all spa-CCs. SCCmec typing showed that 
SCCmec IV is the dominant type followed by SCCmec III, II and V. ST239 (CC5) and ST612 (CC5) 
were the dominant STs. CC8, CC30, CC45, CC5 were amongst the CCs observed and form part of 
the major CCs found worldwide (Stefani et al., 2012). Similar results were reported by another study 
performed at Tygerberg Hospital (Oosthuysen et al., 2013). Altogether 367 S. aureus were collected 
over a one year period in 2009-2010 and 15,3% were MRSA. The dominant spa type was t891 (spa-
CC891) and SCCmec IV was, once again, the most prevalent SCCmec type. The MRSA and MSSA 
isolates clustered into different clones with the exception of ST612 which contained an MSSA isolate. 
In addition to the strain typing methods, agr typing was also performed and the most prevalent agr 
type among the isolates was agr type I, accounting for more than half of the isolates. In both the 
studies performed at Tygerberg Hospital the dominant clone among the MRSA isolates was ST612-
MRSA-IV (in concordance with Jansen van Rensburg et al., 2011) and common worldwide epidemic 
MRSA clones, namely ST239-MRSA-III and ST36-MRSA-II, were also identified (Oosthuysen et al., 
2013; Orth et al., 2013). 
A multicentre study investigated 2709 isolates from bacteraemic patients in four different provinces 
(Western Cape, Free State, Gauteng and KwaZulu-Natal), collected between June 2010 and July 
2012. The prevalence of MRSA was 46%. The five dominant spa types and their corresponding ST 
were as follow; t037-ST239 (CC8), t1257-ST612 (CC8), t045-ST5 (CC5), t064-ST612 (CC8) and 
t012-ST36 (CC30). The strain t037-ST238 was related to HA infections while t1257-ST612 was 
related to CA infections. The dominant SCCmec type was type III followed by type IV and are 
associated with HA and CA infections, respectively (Perovic et al., 2015). 
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To conclude, in South Africa a diverse S. aureus population has been described, with t037-ST239 
(CC8), t1257-ST612 (CC8) and t045-ST5 (CC5) being the most prevalent strains. The MRSA rate 
in South Africa is high and majority of the MRSA isolates belong to SCCmec types IV and III. The 
high prevalence of SCCmec IV is alarming since it has been associated with CA infections. 
Staphylococcus aureus virulence  
S. aureus has the ability to adhere to epithelial surfaces, invade, evade immune responses and 
secrete harmful proteins that contribute to its ability to cause a wide range of infections. S. aureus 
produces multiple virulence factors that work together to establish and maintain an infection. The 
pathogenicity of S. aureus is extremely complex and involves the expression of a diverse range of 
cell wall associated virulence factors as well as extracellular proteins at different stages of infection 
(Bien et al., 2011). During the exponential growth phase, S. aureus expresses a number of surface 
molecules or adhesins. This allows the bacteria, at low density, to adhere to and colonise the host 
cells as well as implanted medical devices (Korem et al., 2003). At a higher cell density the bacteria 
produce exotoxins, which aid in the survival and dissemination of the bacteria as well in establishing 
infection (Korem et al., 2003). This density dependant regulation is under the control of complex 
quorum sensing mechanisms and genetic loci such as accessory gene regulator (agr), sar, sae and 
traP (Korem et al., 2003).  
Adhesins 
S. aureus initiates the colonization process by attaching to surfaces. Multiple adhesins are 
responsible for regulating the attachment to surfaces. Microbial surface component recognizing 
adhesive matrix molecules (MSCRAMMs) are a major class of S. aureus adhesion proteins, which 
are anchored to the peptidoglycan of the cell wall. MSCRAMMs recognise components of the 
extracellular matrix (ECM) or blood plasma. Members of the MSCRAMM family include 
staphylococcal protein A (SpA), clumping factor (Clf) A and B and collagen-binding fibronectin-
binding proteins A and B (FnbpA and FnbpB) (Bien et al., 2011). SpA is one of the main membrane 
bound virulence factors, produced by almost all clinical S. aureus isolates (Huntzinger et al., 2005). 
The protein binds to the von Willebrand factor, which is a large glycoprotein that mediates platelet 
adhesion at damaged endothelial sites (Huntzinger et al., 2005). SpA also interferes with 
Immunoglobulin (Ig)-mediated opsonisation (Patel et al., 1987) and has B-cell super antigenic 
properties - it acts as a natural B-cell toxin by inducing programmed cell death of the targeted B-cell 
(Huntzinger et al., 2005).  
Exoproteins 
A second type of virulence factor is exoproteins, which include exotoxins that promote disease, and 
degradative enzymes that help the organism invade the host. Exoproteins are expressed during the 
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late exponential phase of growth when expression of adhesins is downregulated. This allows the 
bacteria to detach from the original colonization site and establish an invasive infection (George and 
Muir, 2007; Bien et al., 2011). 
There are different types of exotoxins produced by S. aureus. One group has cytolytic activity, and 
includes -haemolysin, -haemolysin, -haemolysin, δ-haemolysin and Panton-Valentine leukocidin 
(PVL). Cytolytic exotoxins form pores in the plasma membrane resulting in lysis of the host cell due 
to content leakage (Bien et al., 2011).  
S. aureus produces another group of exotoxins known as pyrogenic toxin superantigens (PTSAgs). 
These include the staphylococcal enterotoxins (SEA, SEB, SECn, SED, SEE, SEG, SEH and SEI) 
and the toxic shock syndrome toxin-1 (TSST-1). The enteroexotoxins have the ability to stimulate 
proliferation of T-lymphocytes (superantingenicity), and to cause diseases such as food poisoning, 
toxic shock syndrome and staphylococcal scalded skin syndrome (SSSS). S. aureus also produces 
exfoliative toxins (ETA and ETB) which have been recognised to possess mitogenic activity toward 
T-lymphocytes, but whether these exfoliative toxins are superantigens remains controversial (Bien 
et al., 2011).  
The expression of virulence genes in bacteria is tightly regulated; virulence gene expression is turned 
on under appropriate conditions allowing the bacteria to survive within the host and initiate infection 
by evading the host defence system (Huntzinger et al., 2005). S. aureus virulence is regulated by 
multiple global regulatory loci that form part of a complex signalling pathway, which, together with 
environmental and intracellular signals, regulates the expression of virulence factors (George and 
Muir, 2007). S. aureus has developed quorum-sensing systems that enable cell-cell communication 
as well as the regulation of virulence factors (Yarwood and Schlievert, 2003). These quorum-sensing 
systems facilitate its ability to cause disease and occupy niches within the host.  
The accessory gene regulator (agr) 
The accessory gene regulator (agr) locus is one of the quorum-sensing systems that plays a critical 
role in virulence regulation in S. aureus. Previous proteomic and microarray studies have shown that 
the agr locus regulates the expression of more than 70 genes, of which, 23 are known virulence 
factors (George and Muir, 2007). The expression of the agr locus down-regulates the production of 
cell-wall associated virulence factors, such as SpA, and up-regulates the expression of secreted 
virulence factors (exotoxins) such as α-, β-, δ-haemolysin (encoded by hla, hlb, hld) and Panton-
Valentine leukocidin (PVL) (Sakoulas et al., 2002). Bacteria can cause an infection by detaching 
from their original colonization site during the late exponential and stationary growth phases (George 
and Muir, 2007). During these stages of growth, the exotoxins are secreted to assist in detachment 
which can also be regarded as a mechanism for spreading (George and Muir, 2007). The expression 
of the agr locus also appears to play a role in invasion and apoptosis of epithelial cells (Yarwood 
and Schlievert, 2003). 
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Peng et al., first described the agr two-component quorum sensing gene cluster in 1988. It contains 
five genes (agrB, agrD, agrC, agrA and hld) which form part of a multifaceted network (Peng et al., 
1988). The agrD transcript is a propeptide that is processed by AgrB, an integral membrane protein, 
to produce and secrete a mature autoinducing peptide (AIP) to the outside of the cell (Dufour et al., 
2002; George and Muir, 2007). The AIPs activate this two-component signalling pathway by 
activating AgrC, a transmembrane receptor histidine kinase, which undergoes autophosphorylation 
resulting in the activation of AgrA, the response regulator. This activates transcription of the agr locus 
at P2 and P3 (Figure 1.4), resulting in the expression of two RNA transcripts, RNAII and RNAIII (Lina 
et al., 2003; George and Muir, 2007). Expression of RNAIII (the effector molecule) is highly 
dependent on the expression of agrB, agrD, agrC and agrA, which are co-transcribed on RNAII. The 
RNAIII transcript also encodes the exoprotein δ-haemolysin (hld), which serves as a marker for agr 
activity (Figure 1.4) (Cheung et al., 1997).  
 
Figure 1.4: Schematic representation of the agr locus. The expression of RNAII and RNAIII is initiated by 
promoters P2 and P3 respectively. Five genes are expressed, agrB, agrD, agrC, agrA and hld (δ-haemolysin). 
Autoinducing peptides (AIPs) accumulate outside the cell and when a certain threshold is reached, AgrC is 
activated. This results in the expression of RNAIII (the effector molecule). 
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RNAIII: The effector molecule 
The agr locus regulates the expression of virulence factors, firstly, by the direct AgrA-induced 
expression of virulence genes such as phenol soluble modulins (PSM), and secondly, by AgrA-
induced expression of RNAIII which affects the transcription and translation of other virulence 
factors. RNAIII is a multifunctional regulatory molecule that acts as both an antisense and a 
messenger RNA. It consists of 514 nucleotides, encodes δ-haemolysin and forms a stable 14 stem-
loop motif structure (Figure 1.5), which is responsible for the up-regulation of expression of exotoxins 
and the reduced production of surface proteins during the post-exponential and exponential growth 
phases, respectively (Sterba et al., 2003; Huntzinger et al., 2005; George and Muir, 2007). 
Figure 1.5: Schematic representation of RNAIII. The blue region indicates the location of δ-haemolysin, 
while the red areas indicate three known repressor domains. (Source: Guillet et al., 2013). 
 
One way in which RNAIII is involved in the regulation of other genes is by positive regulation of 
translation. An example of this is when the 5’-end of RNAIII competes with an intramolecular RNA 
secondary structure in hla mRNA which sequesters of the hla ribosomal binding site, thereby 
increasing -haemolysin expression (Huntzinger et al., 2005). Another way is the translational 
repression of expression, for example repression of staphylococcal protein A (spa) synthesis. 
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Studies by Novic (2003) and Huntzinger et al. (2005) suggested that sequence complementarity 
between spa mRNA and the 3’-end of RNAIII represses the translation of spa mRNA to inhibit the 
production of SpA (Novick, 2003; Huntzinger et al., 2005). 
agr types  
There are four different agr types, I-IV, defined by sequence variation within the hypervariable region 
of the agr locus (agrB, agrC, agrD) (George and Muir, 2007). Each agr type encodes a separate AIP 
made up of seven to nine amino acids and a pentapeptide thiolactone macrocycle (Figure 1.6). All 
of the different AIPs can bind to the AgrC receptor of all of the agr types, but only a related AIP-AgrC 
(intratype) interaction leads to the activation of AgrA. Intertype AIP-AgrC interactions inhibit the 
phosphorylation of AgrC and can block activation of AgrA. Type I and IV AIPs differ by a single amino 
acid and are the only exception to the intertype interference (George and Muir, 2007). 
 
Figure 1.6: Four different AIPs (amino acid sequences) generated by the different agr types. (Source: 
George & Muir 2007). 
 
Different agr types have been associated with certain diseases, however the exact reason for the 
association between the disease and agr type is not yet clear (Yarwood and Schlievert, 2003). 
Previous studies have reported that agr type I strains are most commonly isolated from clinical 
cultures, while agr type IV is found in the minority of S. aureus isolates (Robinson et al., 2005; Traber 
et al., 2008; Schweizer et al., 2011). Agr types I and II have been associated with resistance to 
glycopeptides, while agr type III strains were isolated from patients with community acquired MRSA 
(CA-MRSA) as well as toxic shock syndrome. Agr type IV is associated with staphylococcal scalded 
skin syndrome (Robinson et al., 2005).  
A study done by Jarraud et al. (2002) investigated the relationship between agr types and disease 
presentation and reported a strong correlation between agr type and genetic background and, 
ultimately, certain disease presentations. A link between agr type IV and exfoliative toxin-mediated 
disease as well as agr type I and II with endocarditis was also observed. Although they could define 
causation, the authors did speculate that the preferential association between certain agr types, 
strain types and toxin genes may result in a more effective activation of virulence factors (Jarraud et 
al., 2002). 
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Agr functionality 
Mutations in agrA or any of the other genes encoded by RNAII can prevent activation of transcription 
at both promoters (Cheung et al., 1997; Traber et al., 2008). This results in failure to produce the 
effector molecule RNAIII, and therefore, altered expression of virulence genes, which can affect 
disease manifestation. S. aureus strains which don’t produce RNAIII are known as agr dysfunctional 
strains, while wild type strains are referred to as agr functional strains (Paulander et al., 2012). The 
prevalence of agr dysfunctional strains can range from 15-60% in HA infections and is much lower 
among CA infections, at approximately 4%.  
The functionality or dysfunctionality of the agr locus can be determined by investigating the 
production of δ-haemolysin (Sakoulas et al., 2002). When the agr locus is expressed, the hld gene 
is also transcribed (as part of RNAIII) resulting in the production of δ-haemolysin; therefore the 
presence of δ-haemolysin suggests agr functionality. There are several methods to determine the 
functionality of the agr locus (Sakoulas et al., 2002; Gagnaire et al., 2012; Paulander et al., 2012). 
These include the observation of haemolysis using a phenotypic synergistic haemolysis assay, 
detecting the presence of δ-haemolysin by whole cell Matrix Assisted Laser Desorption Ionisation 
Time of Flight Mass Spectrometry (MALDI-TOF MS) and the quantitation of RNAIII by qPCR.  
A study done by Schwan et al. (2003) investigated the effects of agr dysfunction on disease in murine 
models and reported that S. aureus agr dysfunctional strains are selected for in wounds and 
abscesses, while haemolytic strains are associated with systemic infections (Schwan et al., 2003). 
Data also suggest that dysfunctionality of the agr locus in S. aureus encourages disease 
development in device related infections (Kong et al., 2006).  
A prominent correlation between dysfunctionality of the agr locus and enhanced biofilm formation 
has been reported, possibly due to the up-regulation of attachment molecules and down-regulation 
of the detachment molecules (Vuong et al., 2000). This can be advantageous for the bacterium, 
because it reduces pro-inflammatory responses within the host (Kong et al., 2006). Biofilm formation 
includes distinct stages: initial attachment to the matrix, cell-to-cell adhesion and proliferation, 
maturation and detachment. In S. aureus, quorum sensing plays a role in biofilm formation at many 
of these stages (Kong et al., 2006). Transition of the cells from free-floating planktonic to a biofilm 
phase is a crucial step. This involves the expression and interaction of several adhesion molecules 
that permits the physiochemical interactions between the planktonic cells and the surface. As biofilm 
matures, small clusters of cells detach from the established structure, which is a fundamental step 
for the spread of infections that are associated with biofilm formation (Kong et al., 2006). Studies by 
Yarwood et al. (2004) suggest that the agr locus plays a role in the detachment of cells from biofilms. 
They performed biofilm time course experiments and reported that the agr locus was, at most times, 
not expressed in most areas of the of the biofilm. However, cells that did express the agr locus were 
present, but were released from the biofilm. The release of virulent S. aureus isolates enables it to 
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spread to new sites (Yarwood et al., 2004). The formation of thicker biofilms in dysfunctional agr 
strains compared to the wild type is due to the inability of the cells to detach from the mature biofilm 
(Vuong et al., 2000). 
The observation that the agr locus is involved in the regulation of many virulence factors leads to the 
assumption that it is vital in S. aureus pathogenesis and that a loss of agr function leads to a 
decrease in virulence (Kong et al., 2006). However, some studies have called into question the 
importance of the agr locus since agr dysfunctional strains are still able to cause disease (Kielian 
and Cheung, 2001; Kong et al., 2006). Previous studies reported no difference in virulence between 
agr dysfunctional and functional strains in mouse brain abscess model and in a rabbit endocarditis 
model (Cheung et al., 1994; Kielian and Cheung, 2001); therefore further investigation is required. 
Problem Statement 
S. aureus is a highly virulent bacterium that is capable of causing a variety of infections when 
exposed to mucous membranes or damaged skin. S. aureus has mastered evading the host immune 
system as well as becoming resistant to antibiotics; strains resistant to the last resort antibiotics, 
such as vancomycin, have already been identified (George and Muir, 2007). Data regarding S. 
aureus epidemiology and agr related virulence characteristics in South Africa is limited. Of the six 
South African epidemiology studies described in Table 1.4, only one investigated the association 
between agr type and strain type. One other study performed in our setting investigated agr type as 
well as agr functionality, but the data is unpublished. Furthermore, data describing the link between 
strain type and agr related virulence characteristics and clinical outcome is also extremely limited. 
Different agr types have been associated with different disease types and agr dysfunction has been 
associated with prolonged bacteraemia, increased resistance to antibiotics and an increased 
mortality (Gagnaire et al., 2012; Paulander et al., 2012). It is clear that the agr locus plays a 
significant role in the regulation of S. aureus virulence factors, but the exact role of agr locus and agr 
functionality is controversial and complex. Investigating the role of strain type and the agr locus in 
virulence and its effects on the clinical outcome may ultimately provide a foundation for progress in 
the treatment and prevention of Staphylococcal disease.  
Aim 
The aim of this study was to determine the effect of genetic background and agr-associated virulence 
characteristics on the clinical outcome of bacteraemic patients at Tygerberg Hospital. 
Objectives 
• To investigate the molecular epidemiology of the S. aureus isolates. 
• To determine the agr type and agr functionality or dysfunctionality of the isolates. 
• To correlate the strain type and agr-associated virulence characteristics with clinical data. 
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 The population structure of patients with Staphylococcus aureus 
bacteraemia at Tygerberg Hospital 
Introduction 
Staphylococcus aureus is one of the most common human pathogens and a leading cause of 
hospital-acquired (HA), healthcare-associated (HCA) and community-acquired (CA) infections 
(Kaech et al., 2006; Perovic et al., 2015). Although invasive S. aureus infections can manifest in 
many different ways, in the majority of these cases the organism can be detected in the patient’s 
blood, resulting in bacteraemia (Turnidge et al., 2009). More than 80% of S. aureus bacteraemia is 
endogenous in origin, which could be a result of the high carriage rates (25-40%) among individuals 
is (von Eiff et al., 2001; Kaech et al., 2006).  
Despite the availability of antibiotics for the treatment of S. aureus bacteraemia, the mortality rate 
remains high and ranges from 29-63% (Perovic et al., 2015). In the last two decades methicillin 
resistant S. aureus (MRSA) isolates, which were previously only found in nosocomial infections, 
have increasingly been isolated from patients with CA infections (Perovic et al., 2015). The 
emergence of CA-MRSA has caused a shift in epidemiology and an increase in the number of MRSA 
infections (Larsen et al., 2008). CA-MRSA isolates mainly cause skin and soft tissue infections, but 
invasive infections such as necrotizing pneumonia and bacteraemia have been described (Larsen 
et al., 2008). Although CA-MRSA isolates are infrequently isolated from blood, they are found in 45-
85% of cases of bacteraemia without focus (Kaech et al., 2006).  
About 40-80% of S. aureus bacteraemia is caused by HA isolates and, in contrast to CA infections, 
most of these cases have an obvious portal of entry, e.g. surgical sites or intravenous catheters. The 
high rate of bacteraemia in health care settings may be due to increasing use of central venous lines, 
as intravenous catheter-related S. aureus bacteraemia has been shown to  be a major problem 
(Kaech et al., 2006).  
S. aureus bacteraemia is a serious disease with a high mortality rate. Difficult to treat MRSA isolates 
are frequently isolated from blood cultures, and isolates resistant to last resort antibiotics have been 
identified. This is threatening our ability to treat infections caused by this organism. In this section 
we describe the study population, clinical data and S. aureus isolates collected from patients who 
presented with S. aureus bacteraemia at Tygerberg Hospital between January 2015 and March 
2017.  
  
Stellenbosch University  https://scholar.sun.ac.za
  23 
Methodology 
Study population 
This study included patients of all ages with S. aureus bacteraemia at Tygerberg Hospital between 
January 2015 and March 2017. Tygerberg Hospital is a 1384 bed tertiary academic hospital in the 
Western Cape of South Africa, which serves a population of approximately 1.9 million. S. aureus 
bacteraemia was defined based on the isolation of S. aureus from at least one blood culture. 
Sample collection 
Blood cultures collected by clinicians as part of routine care were submitted to the National Health 
Laboratory Service (NHLS) microbiology laboratory at Tygerberg Hospital for culture and 
identification; as per routine diagnostic procedures. Blood culture bottles were incubated in the 
BACTEC Blood Culture System (Becton Dickinson, USA) for up to 5 days, or until they flagged 
positive. Standard morphological methods, such as Gram morphology, catalase, mannitol 
fermentation and DNAse activity, were used to identify S. aureus isolates and if necessary the 
Pastorex Staph-Plus test (Bio-Rad Laboratories, USA) was performed. In the case of a negative or 
weakly positive mannitol fermentation or DNAse test, the Vitek®2 system (bioMérieux, France) was 
used to confirm S. aureus identification. Isolates were classified as MRSA using the Vitek®2 system 
(bioMérieux, France). S. aureus isolates were collected from the NHLS microbiology laboratory by 
convenience collection and stored for further analysis in this study. Only non-duplicate isolates were 
included in this study; where duplicate isolates were defined as isolates collected from the same 
patient within a two-week period. 
Ethical approval for this study has been obtained from the Health Research Ethics Committee 
(HREC) of Stellenbosch University (Ethics Reference #: N14/06/065).  
Patient characteristics  
Clinical data of all patients with S. aureus blood infections at Tygerberg Hospital was collected by 
the Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-
SA) as part of routine surveillance. This data includes age, gender, ethnicity, diagnosis, final outcome 
(crude mortality), source of the infection, risk factors as well as the admission date and dates of 
blood culture collection and final outcome.  
The patients were divided into four groups based on age; neonates were defined as babies younger 
than 28 days, children as 28 days to 13 years, adults as older than 14 years but younger than 50 
years and elderly as 50 years and older. Diagnosis was documented as bacteraemia with focus or 
bacteraemia without a known focus, and the final outcome as death or discharge. The length of stay 
(in days) was calculated using the admission and final outcome dates. 
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The infection was classified as hospital acquired (HA), community acquired (CA), or health-care 
associated (HCA). HA infections were defined as a positive blood culture taken more than three days 
after the admission date. HCA infections were defined as positive blood cultures taken at hospital 
admission or within three days of admission, with one or more of the following risk factors: 
• hospitalisation within the year prior to the culture date, 
• prior dialysis in the year before the culture date, 
• prior surgery in the year before the culture date, 
• residence in a long term care facility in the year before the current culture date. 
CA infections were defined, as modified from Perovic et al. (2017), as a positive blood culture taken 
at hospital admission or within three days of admission without any of the above mentioned risk 
factors (Perovic et al., 2017). The time of admission of the patients was often unavailable, therefore 
three days was used as the cut-off instead of 48 hours to avoid potentially misclassifying some 
patients with HAI as CA. 
Results 
Study population and sample collection 
During the study period, 473 S. aureus bacteraemia cases were documented by GERMS-SA and 
199 non-duplicate S. aureus isolates were randomly collected from the NHLS microbiology 
laboratory at Tygerberg Hospital from January 2015 to March 2017. Of the 199 isolates collected, 
clinical profiles were missing for six patients. To determine whether the study sample set is 
representative of the complete population, a comparison was done between the profiles of the 193 
patients for whom S. aureus isolates and clinical data was available and the full data set of 473 
cases recorded by GERMS-SA. No significant difference was observed between the two groups, 
therefore, the study population was concluded to be representative of the entire population of 
patients with S. aureus bacteraemia during the study period (Table 2.1). 
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Table 2.1: Comparison of the patient profiles in the complete clinical data set and the study population. 
 Complete data set (n=473) Study data set (n=193) 
Age in days – median (IQR) 11285 (15450) 11181.5 (15490) 
Adult wards 334 (71%) 138 (71.5%) 
Paediatric wards 139 (29%) 55 (28.5%) 
Male patients 253 (53%) 113 (58.5%) 
Female patients 220 (47%) 80 (42.5%) 
Race   
Black 193 (41%) 83 (43%) 
Coloured 234 (49%) 96 (49.7%) 
White 35 (8%) 10 (5.2%) 
Unknown 11 (2%) 4 (2.1%) 
 
Patient characteristics 
Amongst the study population, the median age of the patients was 30.8 years (11181.5 days; 
IQR=42.4 years), ranging from 2 days to 87 years (Table 2.1). Forty eight percent of the patients 
(n=96) were classified as adults, and 56.8% (n=113) were males (Table 2.2). HA infections 
represented 52.8% (n=105) of the cases, while HCA and CA were 23.1% (n=46) and 19.6% (n=39), 
respectively. The source of the organism for nine (4.5%) of the isolates was unknown (Table 2.2). 
The median length of stay was 24 days (IQR=34.5 days); ranging from 0 to 212 days.  
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Table 2.2: Summary of clinical data for the total study population and classified as MSSA and MRSA 
infections. 
 Total (n=199) MSSA (n=145) MRSA (n=54) 
Length of stay in days – Median (IQR) 24 (34.5) 20 (24) 46 (49) 
Final outcome    
Deceased 58 (29.1%) 39 (26.9%) 19 (35.2%) 
Discharged 141 (70.9%) 106 (73.1%) 35 (64.8%) 
Age groups    
Neonates (<28 days) 21 (10.6%) 9 (6.2%) 12 (22.2%) 
Children (≥28 days – <14 years) 32 (16.1%) 24 (16.6%) 8 (14.8%) 
Adults (≥14 year – <50 years) 96 (48.2%) 71 (49%) 25 (51.9%) 
Elderly (≥50 year) 50 (25.1%) 41 (28.3%) 9 (16.7%) 
Gender    
Male 113 (56.8%) 54 (37.2%) 26 (51%) 
Female 80 (42%) 87 (60%) 26 (48%) 
Unknown 6 (3%) 4 (27.6%) 2 (11%) 
Diagnosis    
Bacteraemia with focus 57 (28.6%) 46 (31.7%) 11 (20.4%) 
Bacteraemia without focus 129 (64.8%) 90 (63.4%) 39 (72.2%) 
Unknown 13 (6.5%) 9 (62%) 4 (74.1%) 
Source of organism    
HA 105 (52.8%) 62 (42.8%) 43 (79.6%) 
HCA 46 (23.1%) 39 (26.9%) 7 (13.7%) 
CA 39 (19.6%) 37 (25.5%) 2 (3.7%) 
Unknown 9 (4.5%) 7 (4.8%) 2 (3.7%) 
 
Twenty seven percent (n=54) of the patients were infected with MRSA isolates. The mortality rate 
amongst patients with MRSA isolates was 35.2% (n=19), while 26,9% (n=39) of patients with MSSA 
infections passed away. Of all the patients 21.6% were infected by HA-MRSA infections, while only 
1% (n=2) of the patients had CA-MRSA infections. HA-MSSA infections accounted for the largest 
group with 31.2% (n=62), followed by HCA-MSSA and CA-MSSA infections accounting for 19.6% 
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(n=39) and 18.6% (n=37) of the cases respectively. Altogether, 19.6% (n=39) of the patients were 
diagnosed with bacteraemia without focus due to MRSA, while 45.2% (n=90) of the patients had 
bacteraemia without focus caused by MSSA infections (Table 2.2). Patients who had bacteraemia 
with a known focus caused by MRSA infections accounted for the smallest number of isolates (5,5%; 
n=11), while 23.1% (n=46) of the patients had bacteraemia with a known focus caused by MSSA 
infections.Figure 2.1 features the diagnoses reported in the study; 64.8% (n=129) of the patients had 
bacteraemia without focus and 28.6% (n=57) had bacteraemia with a known focus (LRTI, bone 
infection, joint infection, skin and soft tissue infection etc.); 13 (6.5%) patients had an unknown 
diagnosis. The crude mortality rate was 29.1% (n=58) during the study period (Table 2.2). 
 
Figure 2.1: Patient diagnoses. 
 
Discussion 
During the period between January 2015 and March 2017, 473 cases of S. aureus bacteraemia were 
identified at Tygerberg hospital as part of the GERMS-SA surveillance. 199 S. aureus isolates were 
collected from the NHLS microbiology laboratory, of which clinical data was collected for 193 of 
these. This subset of cases were concluded to be representative of the larger population. In many 
cases the data of the patients were incomplete and six of the collected isolates had no patient profile 
Abscess, n=2; 1%
Bacteraemia without 
focus (sepsis), n=129; 65%
Bone infection, n=5; 
2.5%
Infective endocarditis, n=1; 0.5%
Joint infection, n=8; 4%
Lower respiratory 
tract infections (LRTI), n=19; 
9.5%
Other infective endocarditis, 
n=1; 0.5%
Pericarditis, n=1; 0.5%
Peritonisis, n=2; 1%
Skin/soft tissue infection, n=18; 9%
Unknown, n=13; 6.5%
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match which is a limitation to this study and may have impacted the results. The missing profiles 
could be because the patients died or were discharged before the clinical data could be collected.  
During this study period the prevalence of MRSA in S. aureus bacteraemia at Tygerberg hospital 
was 27.1%, which was lower than that reported by other studies. Perovic et al. (2015) reported an 
MRSA prevalence of 37% in the Western Cape in 2012 (Perovic et al., 2015), while previous studies 
at Tygerberg hospital have reported that the MRSA prevalence amongst routinely collected S. 
aureus isolates from adult and paediatric patients with S. aureus infections from multiple clinical 
sources from 2008-2012 varied from 30% to 44% (Oosthuysen et al., 2013; Karayem, 2014). 
According to the GERMS-SA annual reports the MRSA prevalence in Gauteng and the Western 
Cape has decreased from 33% in 2015 to 24% in 2017 (Crowther-Gibson & Quan 2016; Crowther-
Gibson & Quan 2017).  
The neonate age group was the only group that showed a higher prevalence of MRSA (57.1%) than 
MSSA. This may be attributed to an MRSA outbreak which occurred in the paediatric and neonatal 
wards during this period. 
In Africa, the prevalence of MRSA varies between countries, however a systematic review on MRSA 
in Africa reported a prevalence of lower than 50% for the majority of the African countries with Egypt 
(52–82%) and Algeria (35-75%) being the exceptions (Falagas et al., 2013).  
In this study we observed a high proportion of HA-MRSA (79.6% of MRSA infections) which is 
consistent with a previous study performed in our setting (Orth et al., 2013); which reported that 88% 
of MRSA infections were HA (Orth et al., 2013). This is not unexpected since antibiotic selective 
pressure is higher in hospitals than in the community and favours the selection of resistant strains 
(Chambers, 2001). 
In our study there was no major difference in distribution of bacteraemia without focus compared to 
bacteraemia with focus, 49% compared to 44% respectively, among CA infections. Furthermore, 
79% of the HA infections were bacteraemia without focus, while 19% were bacteraemia with focus. 
Which states that majority of the HA infections did not have a clearly identifiable portal of entry. A 
previous study performed on blood culture isolates from patients from a Swiss tertiary-care centre 
reported a high prevalence of bacteraemia without focus, ranging between 45 and 85%, among CA 
S. aureus bacteraemia (Kaech et al., 2006). This result is consistent with our study since 49% of the 
CA infections were bacteraemia without focus. The Swiss study did, however, also report that in 
most cases, nosocomial infections have a portal of entry such as surgical sites or intravenous 
catheters (Kaech et al., 2006). Our results are contradictory to this since only 19% of the HA 
infections were as a results of bacteraemia with a known focus. It is possible that, when the clinical 
data was collected, the focus of the bacteraemia may not have been available or communicated to 
the GERMS-SA surveillance officer as the time of data collection. The way in which the diagnosis of 
patients was reported may be a limitation to this study.  
Stellenbosch University  https://scholar.sun.ac.za
  29 
Conclusion 
In conclusion, 199 S. aureus isolates were collected from patients with bacteraemia at Tygerberg 
hospital between 2015 and 2017. Clinical data was collected from 193 of the patients. We report a 
29% mortality rate, and a lower MRSA prevalence (27,1%) than previously described in our setting. 
HA-MRSA accounted for almost/approximately 80% of the MRSA infections and almost half of the 
cases of bacteraemia without focus were CA infections. The following chapters will describe the 
genetic diversity of bacteraemic S. aureus isolates from Tygerberg hospital and their accessory gene 
regulator (agr)-associated virulence characteristics (Chapters 3 and 4); and further investigate the 
impact of strain type and agr-associated virulence characteristics on the clinical data (Chapter 5). 
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 The epidemiology of Staphylococcus aureus bacteraemia isolates from 
patients at Tygerberg Hospital 
Introduction 
The World Health Organisation (WHO) has defined epidemiology as “the study of the distribution 
and determinants of health-related states or events (including disease), and the application of this 
study to the control of diseases and other health problems” (WHO, n.d.). Strain typing is fundamental 
for effective characterisation and discrimination of isolates in order to determine clonal dominance 
and strain relatedness (Oosthuysen et al., 2013). Bacterial isolates are geographically diverse and 
strain typing may be used to determine common and dominant strain types in certain regions 
(Perovic et al., 2015). This may provide insight into evolutionary relationships between isolates and 
permit the study of routes of transmission and to assess the source of the infection (Perovic et al., 
2015).  
There are multiple techniques available for Staphylococcus aureus strain typing amongst which 
staphylococcal protein A (spa) typing and multi-locus sequence typing (MLST) are two of the most 
common methods used. Pulsed field gel electrophoresis (PFGE), single nucleotide polymorphisms 
(SNPs) and whole genome sequencing (WGS) is also available for epidemiological studies (Stefani 
et al., 2012). PFGE is considered to be the gold standard for S. aureus strain typing because of its 
high discriminatory index. However, it is a laborious technique, has limited portability and does not 
have a standardised nomenclature. Based on this, spa typing is often considered an acceptable 
alternative to PFGE, especially when additional methods such as SCCmec typing are included for 
MRSA isolates (Hallin et al., 2007). 
Data regarding the molecular epidemiology of S. aureus in South Africa is limited (Oosthuysen et 
al., 2013). Of the four previous studies in Cape Town and our setting specifically, only two focused 
on blood cultures alone while the other two studied isolates from multiple sources. It is important to 
continuously describe the genetic diversity of isolates in our setting to determine whether clonal 
expansion has taken place. Investigating and understanding molecular characteristics of S. aureus 
isolates is important as this may have an impact on patient outcome and treatment (Perovic et al., 
2015). Information on the genetic relatedness of the isolates may provide a basis for further studies 
comparing virulence-related characteristics of different strains and the impact of these strains on 
patients. 
In this section we aimed to describe the molecular epidemiology of S. aureus isolates collected from 
bacteraemic patients at Tygerberg Hospital. This was done by spa typing of all of the isolates, MLST 
on a subset of isolates and SCCmec typing of MRSA isolates. 
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Methodology 
Sample collection  
S. aureus isolates were collected from blood cultures from patients with bacteraemia at Tygerberg 
Hospital from February 2015 to March 2017, as described in Chapter 2. Isolates were collected from 
the National Health Laboratory Services (NHLS) microbiology diagnostic laboratory at Tygerberg 
Hospital, following routine diagnostic procedures. All isolates were stored on Microbank beads (Pro-
lab diagnostics, Canada) at -80°C. Only non-duplicate isolates were included in this study; where 
duplicate isolates were defined as isolates collected from the same patient within a two-week period. 
Bacterial culture 
S. aureus isolates were retrieved from the Microbank beads by aseptically removing one bead from 
the tube and streaking it out on 5% horse blood agar plate (Green Point Media Lab, South Africa). 
Cultures were aerobically incubated overnight at 37°C. Following overnight incubation, a single 
colony was re-streaked onto a blood agar plate and incubated for a further 24 hours at 37°C to allow 
growth of pure cultures.  
Extraction of genomic DNA 
Genomic DNA was extracted using an in house crude heat-lysis DNA extraction method. A few 
colonies of the pure culture were re-suspended in 400 μl nuclease free water in a micro-centrifuge 
tube and placed in a heating block at 95°C for 30 minutes. The heating step was followed by freezing 
for 30 minutes at -20°C after which the micro-centrifuge tubes were thawed and centrifuged at 
maximum rpm for 10 minutes. The supernatant (containing the DNA) was transferred to a new micro-
centrifuge tube and the extracted DNA was stored at -20°C for use in downstream analyses. A 
negative DNA extraction control was included in every batch of extractions to indicate possible 
contamination.  
spa typing 
The extracted genomic DNA was used in the PCR amplification of the hypervariable region of the 
spa gene. All PCR reactions were set up and run on a Proflex PCR thermal cycler (Applied 
Biosystems, United States). PCR amplification was performed using the KAPA Taq Readymix PCR 
kit (KAPA Biosystems, Switzerland). For each PCR reaction, 12.5 μl of KAPA Taq, 1 μl of each 
primer (10 pmol/μl), 8.5 μl nuclease free water and 2 μl template DNA (extracted genomic DNA) was 
added. A PCR negative control containing all the reagents except genomic DNA was included in 
each PCR run to detect possible contamination. The first primer set, 1095F and 1517R, was used 
to amplify the X region of the spa gene (Table 3.1) (Harmsen et al., 2003). When PCR amplification 
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using these primers failed,  samples were amplified using the second and third primer sets as 
described by Hallin et al. (2009). (Table 3.1).  
Table 3.1: PCR primers for spa typing. (Adapted from Harmsen et al., 2003; Hallin et al., 2009). 
# Primer Sequence (5’ – 3’) Product size (bp) 
1 1095F 
1517R 
AGACGATCCTTCGGTGAGC 
GCTTTTGCAATGTCATTTACTG 
200-500 
2 239F 
1717R 
ACTAGGTGTAGGTATTGCATCTGT 
TCCAGCTAATAACGCTGCACCTAA 
± 1200 
3 1084F 
1618R 
ACAACGTAACGGCTTCATCC 
TTAGCATCTGCATGGTTTGC 
± 550 
 
Amplification consisted of an initial denaturation step at 95°C for 3 minutes; 30 cycles of denaturation 
at 95°C for 30 seconds, primer annealing at 62°C for 30 seconds and elongation at 72°C for 1 minute; 
the reaction was concluded with a final extension at 72°C for 1 minute. The PCR reaction was kept 
at 4°C until removal of the PCR tubes from the PCR machine.  
The PCR products were separated using agarose gel electrophoresis on a 2% agarose gel in 1 x 
TAE (40 mM Tris, 20 mM acetic acid, 1 mM EDTA) for 30 minutes at 120 V. Five microliters of PCR 
product was added to 1 μl Novel Juice (GeneDirex, United States) on parafilm and mixed by pipetting 
up and down; 5 μl of the mixture was used for electrophoresis. A 5 μl of KAPA Universal Ladder 
(KAPA Biosystems) was included in each gel for determination of the sizes of the PCR products. 
Amplicon bands were visualised on agarose gels with the UVItec Alliance 2.7 gel documentation 
system (UVItec, UK). PCR products were sequenced at Inqaba Biotec (Pretoria) using both the 
forward and reverse PCR primers used during amplification (Table 3.1).  
The Ridom StaphType v.2.1.1 (Ridom GmbH, Germany) software package was used for spa type 
elucidation (Harmsen et al., 2003). A built-in Based Upon Repeat Pattern (BURP) algorithm was 
used to cluster the spa types into spa Clonal Complexes (spa-CCs). spa types that were too short 
to presume ancestry (<5 repeats within the hypervariable Xr region of the spa gene) were excluded 
from the BURP analysis. A phylogenetic tree of the identified spa type data was constructed using 
the Molecular Evolutionary Genetic Analysis (MEGA) software using the neighbour-joining method.  
spa typing was performed on 72 of the 199 S. aureus isolates as part of my BSc Honours project in 
2016. 
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Multi-locus sequence typing (MLST) 
MLST was performed as previously described by Enright et al. (2000). Seven housekeeping genes 
(arcC, aroE, glpF, gmk, pta, tpi, yqiL) were amplified and sequenced using the primers in Table 3.2. 
Singleplex PCRs were performed for each gene using extracted genomic DNA. Each reaction 
contained 12.5 μl KAPA Taq Readymix (KAPA Biosystems), 1 μl of each primer (10 pmol/μl), 9.5 μl 
nuclease free water and 1 μl template DNA to make up a final volume of 25 μl. A PCR negative 
control containing all the reagents except genomic DNA was included in each PCR run to detect 
possible contamination.  
The PCR conditions were as follows: an initial denaturation step of 5 minutes at 95°C, followed by 
30 cycles of 95°C for 45 seconds, 56°C for 45 seconds and 72°C for 1 minute. A final elongation 
step was carried out at 72°C for 10 minutes. The PCR reaction was kept at 4°C until removal of the 
PCR tubes from the PCR machine. The PCR products were separated using agarose gel 
electrophoresis as described in the spa typing section. 
PCR products were sequenced at Inqaba Biotec using the forward and reverse primers used during 
the PCR reaction. Sequences for each of the seven housekeeping genes were inspected and 
trimmed in BioEdit Sequence Alignment Editor (Ionis Pharmaceuticals, United States) using allele 1 
of each of the housekeeping genes as reference genes (http://saureus.beta.mlst.net/#). The forward 
and reverse sequences were used to generate a consensus sequence which was then copied into 
the S. aureus MLST database (http://saureus.beta.mlst.net/#) to confer MLST STs.  
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Table 3.2: Primers for the seven housekeeping genes used in MLST. (Source: Enright et al., 2000). 
MLST Group Gene Primer Primer Sequence (5’-3’) Product size Alleles Polymorphic sites 
A arcC 
carbamate kinase 
arcC-Up TTGATTCACCAGCGCGTATTGTC 456 bp 17 19 
arcC-Dn AGGTATCTGCTTCAATCAGCG 
B aroE 
shikimate dehydrogenase 
aroE-Up ATCGGAAATCCTATTTCACATTC 456 bp 17 23 
aroE-Dn GGTGTTGTATTAATAACGATATC 
C glpF 
glycerol kinase 
glpF-Up CTAGGAACTGCAATCTTAATCC 465 bp 11 14 
glpF-Dn TGGTAAAATCGCATGTCCAATTC 
D gmk 
guanylate kinase 
gmk-Up ATCGTTTTATCGGGACCATC 417 bp* 11 13 
gmk-Dn TCATTAACTACAACGTAATCGTA 
E pta 
phosphate acetyltransferase 
pta-Up GTTAAAATCGTATTACCTGAAGG 474 bp 15 18 
pta-Dn GACCCTTTTGTTGAAAAGCTTAA 
F tpi 
triosephosphate isomerase 
tpi-Up TCGTTCATTCTGAACGTCGTGAA 402 bp 14 18 
tpi-Dn TTTGCACCTTCTAACAATTGTAC 
G yqiL 
acetyl coenzyme A acetyltransferase 
yqiL-Up CAGCATACAGGACACCTATTGGC 516 bp 16 19 
yqiL-Dn CGTTGAGGAATCGATACTGGAAC 
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SCCmec typing 
SCCmec typing was performed on all MRSA isolates, as classified using the Vitek®2 system 
(bioMérieux, France), using a multiplex PCR that was previously described by Milheirico et al. (2007). 
The 20 primers described in Table 3.3 were used to amplify different regions of the SCCmec 
element, including genes from the mec and ccr gene complexes, joining regions J1 and J3. The 
mecA primers (mecA P4 and mecA P7) were used as an internal control. SCCmec types were 
determined by the combination of the different amplified targets. 
Table 3.3: Primers used in SCCmec typing by multiplex PCR. (Source: Milheirico et al., 2007). 
Primer Name Primer Sequence (5’-3’) Target: 
Type; region 
Size (bp) 
kdpF1 
kdpR1 
AATCATCTGCCATTGGTGATGC 
CGAATGAAGTGAAAGAAAGTGG 
II; J1 284 
CIF2 F2 
CIF2 R2 
TTCGAGTTGCTGATGAAGAAGG 
ATTTACCACAAGGACTACCAGC 
I; J1 495 
RIF5 F10 
RIF5 R13 
TTCTTAAGTACACGCTGAATCG 
GTCACAGTAATTCCATCAATGC 
III; J3 414 
SCCmec III J1 F 
SCCmec III J1 R 
CATTTGTGAAACACAGTACG 
GTTATTGAGACTCCTAAAGC 
III; J1 243 
SCCmec V J1 F 
SCCmec V J1 R 
TTCTCCATTCTTGTTCATCC 
AGAGACTACTGACTTAAGTGG 
V; J1 377 
mecI P2 
mecI P3 
ATCAAGACTTGCATTCAGGC 
GCGGTTTCAATTCACTTGTC 
II, III; mec complex 209 
dcs F2 
dcs R1 
CATCCTATGATAGCTTGGTC 
CTAAATCATAGCCATGACCG 
I, II, IV, VI; J3 342 
mecA P4 
mecA P7 
TCCAGATTACAACTTCACCAGG 
CCACTTCATATCTTGTAACG 
Internal control 162 
ccrB2 F2 
ccrB2 R2 
AGTTTCTCAGAATTCGAACG 
CCGATATAGAAWGGGTTAGC 
II, IV; ccr 311 
ccrC F2 
ccrC R2 
GTACTCGTTACAATGTTTGG 
ATAATGGCTTCATGCTTACC 
V; ccr 449 
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PCR amplification was performed using the KAPA 2G Fast Multiplex Mix Kit (2X) (KAPA Biosystems) 
and each reaction had a final volume of 25 μl. For each PCR reaction 12.5 μl of KAPA 2G Fast 
Multiplex Mix Kit (2X), 0.1 μl of each primer in Table 3.3 (50 pmol/μl), 9.5 μl nuclease free water and 
1 μl template DNA (extracted genomic DNA) was added. Seven control strains Table 3.4, each 
representing a different SCCmec type, were included in every multiplex PCR run. A PCR negative 
control containing all the reagents except genomic DNA was included in each PCR run to detect 
possible contamination. 
Table 3.4: SCCmec typing control strains. (Adapted from Milheirico et al., 2007; Nel van Zyl 2016). 
SCCmec type Control strain Origin 
I BAA-38 ATCC (American Type Culture Collection) 
II BAA-1681 ATCC 
III BAA-39 ATCC 
IV BAA-1680 ATCC 
V WIS Division of Medical Microbiology, University of Cape Town 
V BAA-1688 ATCC 
VI BAA-42 ATCC 
 
The PCR cycle conditions were as follow: 95°C initial denaturation for three minutes; 30 cycles of 
denaturation at 95°C for 15 seconds, primer annealing at 60°C for 30 seconds and elongation at 
72°C for 45 seconds; the reaction was concluded with a final extension at 72°C for three minutes. 
The PCR reaction was kept at 4°C until removal of the PCR tubes from the PCR machine.  
The PCR products were separated using agarose gel electrophoresis, essentially as previously 
described, on a 3% agarose gel in 1 x TAE buffer for 80 minutes at 100 V (Nel van Zyl, 2016). The 
band patterns of the isolates were compared to those of the control strains in order to assign 
SCCmec types.  
Results 
The molecular epidemiology was determined for the 199 S. aureus isolates collected from blood 
cultures from bacteraemic patients at Tygerberg Hospital from January 2015 to March 2017, as 
described in Chapter 2.  
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spa typing  
spa typing provided information on the genetic diversity of the identified S. aureus isolates. Figure 
3.1 is a representative spa typing gel, showing the presence of the expected bands of between 200 
bp and 500 bp. The different product sizes are as a result of the different numbers of repeats within 
the hypervariable Xr region of the spa gene. The band size is however not an indication of the spa 
type and cannot be used to discriminate between strain types; sequence analysis is essential for 
spa type elucidation. A total of 189 (95%) of the 199 isolates were successfully typed. PCR 
amplification failed for 10 isolates even after repeated DNA extraction and attempted PCR 
amplification with all three spa typing primer sets, and were classified as non-typeable.  
Figure 3.1: Representative agarose gel of the spa typing PCR products. Lane 1 contains the DNA ladder, 
lanes 3-11 contain spa PCR products of ten S. aureus isolates and lanes 12 and 13 contain the DNA extraction 
and PCR negative controls respectively. 
 
Interpretable sequencing results were obtained for all spa PCR products. spa types with globally 
recognised patterns through the Ridom Spa server are labelled with a “t” before the succession 
number (Shutt et al., 2005). Seventy-three different spa types were identified, of which seven (9.6%) 
were identified as new spa types namely t18222 – t18228. t045 (n=22; 11.1%) was the most 
abundant spa type followed by t318 (n=15; 7.5%) and t002 (n=13; 6.5%). The BURP algorithm 
clustered the 73 spa types into twelve spa-CCs (Table 3.5, Figure 3.2), which accounted for 76.9% 
(n=153) of the isolates. spa-CC 002 is the largest group of isolates (n=42; 21.1%), followed by spa-
CC 012 (n=34; 17%), spa-CC 701/2360 (n=23; 11.6%) and spa-CC 032/578 (n=13; 6.5%). No 
founders were identified for four of the spa-CCs, and 18 (n=32; 16.1%) of the spa types were 
classified as singletons (Table 3.5). Three spa types (n=4; 2%) were excluded from the analysis 
since they contained less than five repeats within the hypervariable region of the spa gene and 
ancestry could not be assumed 
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Table 3.5: spa-CCs identified using the BURP algorithm of Ridom StaphType. 
Clonal Complex (CC) spa types  spa types (n) Isolates (n) MRSA/MSSA/Mixed 
spa-CC 002 t002, t045, t071, t242, t509, t1154, t5213, t15306 8 42 Mixed 
spa-CC 012 t012, t018, t021, t037, t318, t399, t1848 7 34 Mixed 
spa-CC 701/2360 t190, t701, t1257, t1476, t1971, t2360, t4315 7 23 Mixed 
spa-CC 015/073 t015, t073, t116, t331, t1078, t2171 6 10 MSSA 
spa-CC 084 t084, t085, t346, t14791, t18222 5 10 MSSA 
spa-CC 032/578 t032, t578, t891, t1036 4 13 Mixed 
spa-CC NF 174 t127, t174, t18225, t18227 4 7 MSSA 
spa-CC NF 5916 t1490, t5916, t18226 3 3 Mixed 
spa-CC NF 9 t148, t2409 2 4 Mixed 
spa-CC NF 10 t317, t6712 2 3 MSSA 
spa-CC NF 11 t1597, t11970 2 2 MSSA 
spa-CC NF 12 t258, t349 2 2 MSSA 
Singletons t008, t091, t189, t223, t267, t269, t272, t355, t888, t1467, t2442, 
t2526, t2763, t6267, t10509 
18 32 Mixed 
spa types excluded t026, t2304, t9909,  3 4 MSSA 
Non-typeable N/A N/A 10 MSSA 
*The founder spa types for each spa-CC are highlighted in bold.  
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Figure 3.2: Graphical representation of the spa-CCs identified using the BURP algorithm of Ridom StaphType. 
The blue circles represent the founders of the clusters, while the yellow circles represent the co-founders and the black 
circles represent the other spa types present in the cluster. The size of the circle is proportional to the number of isolates 
belonging to the spa type, but is not comparable between cluster diagrams. 
Spa-CC 002 Spa-CC 012
Spa-CC 701/2360
Spa-CC 015/073 Spa-CC 084
Spa-CC 174
Spa-CC 032
Spa-CC 5916
Spa-CC NF9 Spa-CC NF10
Spa-CC NF11
Spa-CC NF12
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Multi-locus sequence typing (MLST) 
MLST was performed on a subset of isolates based on the spa typing results. At least one 
representative isolate from each of the major spa-CCs was selected for MLST. Altogether 14 isolates 
were typed and 11 different STs were identified (Table 3.6). Two representative isolates from the 
dominant spa-CC 002 were ST5, while one isolate was typed as an unknown ST that is most closely 
related to ST5. The second largest cluster, spa-CC 012, contained ST30, ST1865 and ST239. spa-
CC 701/2360, contained ST8. Amplification of the genes aroE and yqiL failed for two isolates from 
spa-CC NF10, therefore they were designated non-typeable by MLST (Table 3.6). 
Table 3.6: MLST STs from selected representative isolates based of spa typing results. 
 spa-CC spa type MLST ST MLST CC 
002  
 
t002 5 5 
t045 NT (closest related ST is ST5) 5 
t045 5 5 
012 
 
t012 30 30 
t318 1865 30 
t037 239 5 
701/2360 t1476 8 5 
015/073 t015 508 45 
084 t084 15 15 
032/578 t032 22 22 
NF7 t127 1 5 
NF9 t148 72 5 
NF10 t317 NT NT 
t6712 NT NT 
*NT: Non-typeable by MLST 
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SCCmec typing 
Fifty-four (27.1%) of the S. aureus isolates were reported to be methicillin resistant by the Vitek II 
Advanced Expert System (Biomerieux). SCCmec typing was performed on all MRSA isolates as 
described by Milheirico et al., (2009). Figure 3.3 is a representative SCCmec  typing gel, showing 
the typing of the controls as reference and 10 isolates. The SCCmec types of ninety-four percent 
(n=51) of the MRSA could be determined. The remaining three isolates had banding patterns that 
were non-typeable by the protocol from Milheirico et al. (2009) (Figure 3.4). 
Figure 3.3: Representative SCCmec typing gel. Three percent agarose gel for the assignment of SCCmec 
types to isolates. Lane 1 and 19 contain the molecular weight ladder; lanes 2-7 contain the controls for 
SCCmec type I-VI respectively; lanes 8-17 contain ten isolates and lane 18 contains a negative PCR control. 
Isolates in lanes 9, 11, and 14 were identified as SCCmec type IV; lanes 10, 12 and 17 as a novel variant; 
lanes 13 and 15 as SCCmec type II and lane 8 and 16 were non-typeable isolates. 
 
The dominant SCCmec types were SCCmec type IV and a novel variant (NV) that has previously 
been described in our setting (Karayem, 2014); each of these types were present in 19 (35.2%) 
isolates (Figure 3.4). SCCmec type III (n=7; 13%) was the third most prevalent type followed by 
SCCmec type II (n=6; 11.1%) (Figure 3.4). 
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Figure 3.4: The SCCmec type distribution amongst the MRSA isolates. 
Phylogeny of S. aureus isolates based on spa typing 
The MLST, SCCmec typing and methicillin resistance results were correlated on a neighbour-joining 
phylogenetic tree constructed in MEGA using the spa typing data (Figure 3.5). Of the twelve spa-
CCs identified, six contained only MSSA isolates (spa-CC 015/037, spa-CC 084, spa-CC 174, spa-
CC NF10, spa-CC NF11, spa-CC NF12) and six (spa-CC 002, spa-CC 012, spa-CC 701/2360, spa-
CC 032/578, spa-CC 5916, spa-CC NF9) consisted of both MRSA and MSSA isolates (Figure 
3.5).The dominant MSSA clone was t318-ST1865 (n=14/154; 9.7%), and has previously been 
described at Tygerberg Hospital followed by t002-ST5 (n=13/154; 9%) and t355 (n=9/154; 6.2%). 
Amongst MRSA strains, t045-ST5-MRSA-NV accounted for 19 (35.2%) of the strains. This was 
followed by t037-ST239-MRSA-III and t032-ST22-MRSA-IV, each accounting for seven (13%) 
MRSA isolates. Strain type t1257-MRSA-IV was assigned to five (9.3%) of the MRSA isolates, and 
four (7.4%) of the isolates were t012-ST30-MRSA-II. Ten MRSA strain types were limited to one or 
two isolates only.   
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Figure 3.5: Phylogeny of the S. aureus isolates based on spa type. The phylogeny was constructed with the spa 
typing results, based on the neighbour-joining algorithm in MEGA. The MLST and SCCmec typing results were 
superimposed on the spa typing phylogeny. The numbers on the end on each branch are the spa type, ST (where 
analysed), SCCmec type and spa-CC. The strains in bold are MRSA isolates and the highlighted strains indicate the 
isolates selected for MLST. 
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Discussion 
This chapter describes the genetic structure of S. aureus isolates collected from bacteraemic 
patients at Tygerberg Hospital between January 2015 and March 2017. The MRSA isolates were 
shown to be more clonal than the MSSA isolates. The dominant MSSA clone was t318-ST1865 
(CC30) and, although not one of the most common clones, has previously been described amongst 
blood culture isolates from Tygerberg Hospital during 2008 and 2009 (Orth et al., 2013). t318-
ST1865 has also been described among isolates from Egypt, Indonesia and multiple countries in 
Europe (Deurenberg et al., 2010; Enany et al., 2010). 
The dominant strain type among the MRSA isolates was t045-ST5-MRSA-NV. ST5-MRSA has 
previously been described in South-Africa, however, it was linked with various SCCmec types. For 
example, in Kwa-Zulu Natal it was identified with SCCmec III (Shittu et al., 2009) and IV (Essa et al., 
2009), while in Cape Town it was identified with SCCmec type I (Jansen van Rensburg et al., 2011). 
This indicates that SCCmec elements are easily transferred between and acquired by different 
strains through horizontal gene transfer due to fact that it is a mobile genetic element. ST5-MRSA-
IV (also known as the paediatric clone) has also been found in France, Portugal and USA (Essa et 
al., 2009). A multicentre study performed in South Africa reported the presence of t045-ST5-MRSA 
with a non-typeable SCCmec element (Perovic et al., 2015). In this study 19 t045-ST5-MRSA-NV 
isolates were collected from paediatric patients and t045 was identified as an paediatric and neonatal 
outbreak strain which could have resulted in an elevated MRSA rate, especially among the neonate 
and children age groups. 
The SCCmec type NV identified in this study has previously been identified among 16.7% of MRSA 
isolates in our setting by Karayem (2014) and has been described by Nel van Zyl (2016). Following 
WGS of a SCCmec type NV S. aureus isolate the NV was found to be similar to SCCmec type I (Nel 
van Zyl 2016). The NV carries the same mec type (Class B) and ccr type (ccrA1ccrB1) as SCCmec 
type I as well as the two insertion sequences, namely IS341 and IS1272. However, a SCCHg-like 
element was identified between the J3 and orfX regions of the SCCmec type NV (Nel van Zyl 2016). 
The clone t037-ST239-MRSA-III (CC5) (n=7; 3.5%) described in our study is a pandemic clone also 
known as the Brazilian/Hungarian clone (Friedrich et al., 2008; Shittu et al., 2009). It has been 
widespread in hospitals in multiple countries in South America, Asia and Europe (Friedrich et al., 
2008). In South Africa, it was first reported in 2009 in 16.4% of isolates from health-care institutions 
in Kwa-Zulu-Natal (Durban, Pietermaritzburg and Epangeni) (Shittu et al., 2009). The clone t032-
ST22-MRSA-IV (CC32) has infrequently been previously described in South Africa in isolates from 
multiple infection sources from 2005-2008 and to our knowledge has not been described elsewhere 
in Africa (Jansen van Rensburg et al., 2011; Perovic et al., 2015). This clone is however one of the 
most frequently (10.4%) described spa types worldwide (Friedrich et al., 2008; 
https://www.spaserver.ridom.de). 
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Although not selected for MLST, the strain type t1257-MRSA-IV (n=5; 2.5%), identified in this study, 
has been reported to be associated with ST612, a local dominant ST in South Africa between 2010-
2012 (Perovic et al., 2015). ST612 has only been described in hospitals in South Africa and Australia 
suggesting that clonal expansion of an old local clone has taken place over time (Jansen van 
Rensburg et al., 2011). Strain type t012 has frequently been described among HA infections in South 
Africa belonging to ST22, ST36, ST239 and ST612 (Orth et al., 2013; Perovic et al., 2015, 2017), 
however in our study it was described as t012-ST30-MRSA-II (CC30). ST30 has previously also 
been described in Egypt and Madagascar (Abdulgader et al., 2015).  
Limitations of this study include that the gold standard for S. aureus strain typing, PFGE, was not 
performed and that due to the high expense of MLST only a subset of isolates were subjected to 
MLST. A single colony was selected for the analysis, which may have caused biasing of the genotype 
present in patients infected by multiple clones. Future studies may include PFGE typing of the 
sample set as well as further SCCmec typing for the three isolates that were untypeable by the 
Milheirico et al. (2007) protocol.  
Conclusion 
Our results suggest that the S. aureus population amongst bacteremia patients at Tygerberg hospital 
between 2015 and 2017 was highly diverse. Seventy-three different spa types were identified and 
clustered into 12 spa-CCs with spa-CC 002 being the dominant spa type. The most common spa 
type among the MSSA isolates was t318-ST1865 and MRSA strains were shown to be more clonal 
than MSSA strains. Pandemic MRSA clones are circulating in our setting, namely t037-ST239-
MRSA-III, t032-ST22-MRSA-IV and t012-ST36-MRSA-II. The novel variant SCCmec type was 
predominant in this population and it was linked with t045-ST5-MRSA. Genotyping data from this 
chapter was used to investigate associations between strain type and agr-associated virulence 
(Chapter 4) as well as strain type and clinical data (Chapter 5). 
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 The agr-related virulence characteristics of Staphylococcus aureus 
bacteraemia isolates from patients at Tygerberg Hospital 
Introduction 
Staphylococcus aureus is an opportunistic pathogen responsible for a wide range of superficial as 
well as toxin-associated infections. There are several virulence factors involved in establishing and 
maintaining S. aureus infections and many of these are regulated by the accessory gene regulator 
(agr) locus. Four different agr types, I-IV, have been described; defined by sequence variation within 
the hypervariable region of the agr locus (agrB, agrC, agrD) (George and Muir, 2007). These agr 
types have been associated with certain types of infections (Yarwood and Schlievert, 2003). Agr 
type I strains are prevalent in hospital acquired (HA) infections (Sakoulas et al., 2002), agr types I 
and II have been associated with resistance to glycopeptides (Robinson et al., 2005), agr type III is 
common amongst community acquired methicillin resistant S. aureus (CA-MRSA) infections and has 
been associated with toxic shock syndrome, while agr type IV is associated with staphylococcal 
scalded skin syndrome (Robinson et al., 2005). 
AgrA is responsible for the regulation of many phenol soluble modulins (PSM) as well as genes 
involved in metabolism, but the main effector of the agr locus is RNAIII (Vuong et al., 2004, Gagnaire 
et al., 2012). RNAIII regulates the switch between expression of surface proteins and exotoxins and 
also includes the mRNA for δ-haemolysin (26 amino acids); production of which is an indicator of 
agr functionality (Sakoulas et al., 2002). Because of its involvement in the expression of virulence 
factors, it may be assumed that the agr locus plays an important role in pathogenesis. The agr locus 
is considered important for transmission between hosts and essential in strains with high virulence 
(Paulander, 2012) and agr dysfunctional strains have been shown to be less virulent than wild type 
strains (Abdelnour et al., 1993; Gillaspy et al., 1995; Blevins et al., 2003; George and Muir, 2007).  
The vast majority of clinical isolates have a functional agr locus and therefore produce RNAIII. 
However, agr dysfunctional strains- lacking RNAIII and therefore δ-haemolysin, have been isolated 
from patients with a variety of nosocomial infections (Shopsin et al., 2008). Previous studies have 
reported that essentially all S. aureus strains from CA infections have a functional agr locus; and 
that carriage of S. aureus with a dysfunctional agr amongst healthy individuals is approximately 4%. 
This carriage was found to be associated with previous hospitalisation or hospital exposure (Shopsin 
et al., 2008; Butterfield et al., 2011; Tsuji et al., 2011).  In contrast, agr dysfunctionality ranges from 
15 to 60% in HA and health care associated (HCA) S. aureus infections (Paulander, 2012). 
In our setting, agr typing has only been performed in two previous studies, while only a single study 
performed agr functionality using the synergistic functionality assay. This highlights the lack of agr 
typing and functionality data in this setting. In this chapter we describe the agr related virulence 
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characteristics of the S. aureus isolates from bacteraemic patients at Tygerberg hospital with regards 
to agr type and agr functionality.  
Methodology 
Agr typing and functionality assays were performed on the 199 S. aureus isolates from blood cultures 
collected from bacteraemic patients at Tygerberg Hospital between January 2015 to March 2017, as 
described in Chapter 2.  
Agr typing 
Agr typing was performed by multiplex PCR targeting the hypervariable regions of the agr locus  
(Lina et al., 2003). The extracted genomic DNA (Chapter 3) was used for the PCR amplification. All 
PCR reactions were set up and run in the PCR laboratory in the Medical Microbiology Division in 
Tygerberg Hospital. Agr typing was performed in a Proflex PCR thermal cycler (Applied Biosystems, 
United States) using the KAPA Taq Readymix PCR kit (KAPA Biosystems, United States). For each 
PCR reaction 12.5 μl of KAPA Taq master mix (2X), 1 μl of each primer (10 pmol/μl), 8.5 μl nuclease 
free water and 2 μl template DNA was added. A no-template control containing all the reagents 
except genomic DNA was included in each PCR run to detect contamination. A universal forward 
primer, for all four agr types, and four reverse primers, specific to each agr type, were used (Table 
4.1). 
Table 4.1: PCR primers used for agr typing. (Lina et al., 2003). 
Primer Sequence (5’ – 3’) Product sizes (bp) 
pan agr F ATGCACATGGTGCACATGC N/A 
agrI R GTCACAAGTACTATAAGCTGCGAT 439 
agrII R TATTACTAATTGAAAAGTGCCATAGC 572 
agrIII R GTAATGTAATAGCTTGTATAATAATACCCAG 321 
agrIV R CGATAATGCCGTAATACCCG 657 
 
The PCR cycle conditions were as follows: 95°C initial denaturation for 3 minutes; 35-40 cycles of 
denaturation at 95°C for 30 seconds, primer annealing at 55°C for 30 seconds and elongation at 
72°C for 1 minute; with a final extension at 72°C for 1 minute. The PCR reactions were kept at 4°C 
until removal of the PCR tubes from the PCR machine.  
The PCR products were separated using agarose gel electrophoresis on a 2.5% agarose gel in 1 x 
TAE buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA) for 80 minutes at 100 V. To allow 
visualisation of the DNA, 5 μl of each PCR product was added to 1 μl of Novel Juice (GeneDireX, 
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United States) on parafilm and mixed by pipetting up and down; 5 μl of the mixture was used for 
electrophoresis. The first lane of each agarose gel contained 5 μl of KAPA Universal Ladder (KAPA 
Biosystems) for the size determination of the PCR products. Agarose gels were visualised under UV 
light using the UVItec Alliance 2.7 gel documentation system (UVItec, UK) and agr type was 
assigned based on the PCR product size (Table 4.1). Previously typed isolates TKN91 (agrI), TKB72 
(agrII), TKB83 (agrIII) and THW 187 (agrIV) were added to each set of reactions as positive controls 
(Karayem, 2014). 
Isolates that could not be typed using the KAPA 2G Taq Readymix were typed using KAPA Taq 2G 
Robust Readymix (Kapa Biosystems) and/or singleplex PCR, using the conditions described above 
with an annealing temperature of 58°C and the addition of 2.5 μl MgCl2 (25 mM).  
Agr typing was performed on 72 of the 199 S. aureus isolates as part of my BSc Honours project in 
2016. 
Agr functionality 
Phenotypic synergistic agr functionality assay 
Functionality of the agr operon was determined by detecting δ-haemolysin activity using the 
phenotypic synergistic haemolysis assay (Sakoulas et al., 2002). This assay is based on the 
synergistic activity of β-haemolysin and δ-haemolysin in the haemolysis of sheep red blood cells. S. 
aureus RN4220 is a β-haemolytic control strain which causes partial haemolysis of red blood cells. 
When a δ-haemolysin producing (agr functional) isolate is cross-streaked with RN4220, the 
synergistic activity of δ- and β-haemolysin results in enhanced or complete haemolysis within the β-
haemolysis zone of S. aureus RN4220 on sheep blood agar plates, allowing its classification as an 
agr functional isolate (Sakoulas et al., 2002). 
S. aureus strain RN4420 was streaked out vertically down the middle of a sheep blood agar plate 
(Green Point Media Lab, South Africa) and the test isolates were streaked out perpendicular to 
RN4220 with the haemolysis zones overlapping. The plates were incubated aerobically at 37°C 
overnight. δ-haemolysin activity was indicated by enhanced or complete haemolysis within the β-
haemolysis zone of S. aureus RN4220. The experiment was performed in triplicate for each isolate 
and read by at least two individuals to ensure that the results were properly documented. Positive 
and negative controls, NRS 149 and NRS 155 respectively, were included for each batch. 
Agr functionality using the phenotypic synergistic assay was determined for 72 of the 199 S. aureus 
isolates as part of my BSc Honours project in 2016. 
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δ-haemolysin toxin screening by MALDI-TOF MS 
Agr functionality was also determined using whole cell matrix assisted laser desorption ionisation 
time of flight mass spectrometry (MALDI-TOF MS) to detect the δ-haemolysin toxin, as described by 
Gagnaire et al. (2012). This assay was included to confirm results from the phenotypic synergistic 
assay, since results from the phenotypic synergistic assay are subjective. Wild-type δ-haemolysin 
toxin from S. aureus is detected as a peak at 3005±5 Thomson (Th), while a 3035±5 Th peak is 
detected in the case of a functional allelic variant of δ-haemolysin (a substitution causing an amino 
acid change from glycine to serine at amino acid 10 in δ-haemolysin). Agr functional strains are 
therefore identified based on the presence of either the WT (3005±5 Th) or variant (3035±5 Th) toxin 
peak; while dysfunctional strains lack both peaks (Figure 4.1). 
Figure 4.1: Detection of δ-haemolysin toxin peaks by MALDI-TOF MS. Graphs (a) and (b) are  both δ-
haemolysin negative strains showing no peak at 3005±WT Th or 3035±5G10S Th, while (c) and (d) are two 
isolates expressing the variant δ-haemolysin toxin; they lack the 3005±5WT Th peak but have a 3035±5G10S Th 
peak, (e) and (f) are isolates positive for δ-haemolysin showing the 3005±5WT Th peak. (Source: Gagnaire et 
al., 2012). 
 
For the whole cell MALDI-TOF MS analysis, isolates were grown on blood agar plates (Green Point 
Media Lab) incubated aerobically at 37°C overnight. One colony was deposited on a stainless steel 
target slide (Biomerieux, France) and coated with α-cyano-4-hydroxycinnamic acid (CHCA) as 
matrix. Escherichia coli ATCC8739 was used as a control strain for calibration. Mass spectrometry 
was performed on the VITEK® MS (Biomerieux) at AMPATH at N1 City Hospital in Goodwood, Cape 
Town, using conventional settings determined for bacterial identification. The VITEK® MS Prep 
Station Software V2.3.2 (Biomerieux) was used to prepare the target slide and the VITEK® MS 
Acquisition Station Software was used to visualise the peptide mass fingerprint (PMF). Peaks of 
(a) 
 
(b) 
 
(c) 
 
(d) 
 
(e) 
 
(f) 
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interest (3005±5WT Th and 3035±5G10S Th) were identified manually by analysing the PMFs 
generated for all the analytes in the sample. Agr functionality and dysfunctionality were defined by 
the presence or absence of the peaks respectively. All isolates were run in duplicate and peaks were 
interpreted as the average of the two replicates.  
Statistical analysis 
The association between infections with MRSA and the covariates agr type and agr functionality was 
investigated using univariable and multivariable logistic regression for categorical variables. The two-
sample Wilcoxon rank-sum (Mann-Whitney) test was used for univariable analysis, and survival 
analysis was conducted for the multivariate model. Statistical analysis was done using Stata v.15 
(StataCorp LLC, USA) and P values of <0.05 were interpreted as significant. 
Results 
Agr type 
Agr typing was successful for all 199 isolates and all four agr types were identified based on the agr 
product size (Figure 4.2). Agr type I was the most common type, identified in 99 (49.7%) isolates, 
followed by agr type II in 57 (28.6%) isolates and type III in 37 (18.6%) isolates. Only six isolates 
(3%) were identified as agr type IV. The distribution of agr types amongst MRSA and methicillin 
susceptible S. aureus (MSSA) isolates was similar, with agr type I being the dominant type followed 
by agr types II, III and IV (Table 4.2). 
 
Figure 4.2: Representative agr typing gel. 2.5% agarose gel for the assignment of agr types to isolates. 
Lane 1 and 17 contain the KAPA Universal Ladder; lanes 2-5 contain the positive controls for agr type I-IV 
respectively; lanes 6-15 contain ten isolates and lane 16 contains a no template PCR control. Isolates in lanes 
9, 10 and 12-14 were identified as agr type I; lanes 7 and 8 as agr type II; lanes 1 and 15 as agr type III and 
lane 11 as agr type IV. 
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Figure 4.3: Distribution of agr types. The data labels indicate the number of isolates within each agr type. 
 
Table 4.2: Distribution of agr types among MRSA and MSSA isolates. 
 
Total No (%) MSSA No (%) MRSA No (%) p value* 
agr I 99 (49.7) 72 (49.7) 27 (50) - 
agr II 57 (28.6) 37 (25.5) 20 (37) 0.31 
agr III 37 (18.6) 30 (20.7) 7 (13) 0.32 
agr IV 6 (3) 6 (4.1) 0 (0) 0.57 
*p value <0.05 was interpreted as significant. 
 
Agr functionality 
Phenotypic synergistic agr functionality assay 
The agr functionality assay, based on the phenotypic detection of δ-haemolysis, identified 25 
(12.6%) of the isolates as agr dysfunctional based on the lack of enhanced haemolysis within the β-
haemolysis zone of the RN4220 control strain, indicating the absence of δ-haemolysin production 
(Figure 4.4). Enhanced haemolysis, indicating the production of δ-haemolysin, was detected for the 
remaining 174 isolates; which were classified as agr functional. 
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Figure 4.4: Determining agr functionality using the synergistic activity of β- and δ-haemolysin. The 
negative (NRS155) and positive (NRS149) strains are displayed on the left. Isolates 1 and 5 were classified 
agr dysfunctional based on of the absence of a complete haemolysis zone within the β-haemolytic zone of 
RN4220. Isolates 2, 3 and 4 were classified as agr functional, as indicated by the complete haemolysis of the 
blood cells within the β-haemolytic zone of RN4220. 
Screening for δ-haemolysin toxin by MALDI-TOF MS 
All isolates were also tested for the presence of the δ-haemolysin toxin using MALDI-TOF MS, as 
previously described by Gagnaire et al. (2012). One hundred and fifty isolates (75.4%) had the 
3005±5WT δ-haemolysin toxin peak, five (2.5%) had the 3035±5G10S peak, and an additional 32 
(16.1%) isolates had both the 3005±5WT and 3035±5G10S peaks (Figure 4.5, Table 4.3). All 187 (94%) 
isolates in which peaks were detected were classified as agr functional by MALDI-TOF MS. Twelve 
(6%) isolates had no peak and were classified as agr dysfunctional by MALDI-TOF MS (Table 4.3). 
 
Figure 4.5: Determining agr functionality by the detection of δ-haemolysin toxin peaks by MALDI-TOF 
MS. Graphs (a), (b) and (c) represent agr functional isolates. Graph (a) indicates an isolate containing the wild 
type peak (3005±WTTh). Graph (b) shows an isolate expressing the variant δ-haemolysin toxin (3035±5G10S 
(a) 
 
 
(b) 
 
 
(c) 
 
 
(d) 
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Th), while graph (c) shows a strain with both peaks (3005±WT Th and 3035±5G10S Th). The isolate presented 
in graph (d) is δ-haemolysin negative and contains no peak. 
Table 4.3: MALDI-TOF MS agr functionality results. 
 MALDI-TOF MS detected δ-haemolysin peaks Number of isolates 
Agr functional 
3005±5WT 150 (75.4%) 
3035±5G10S 5 (2.5%) 
Both peaks 32 (16.1%) 
Agr dysfunctional No peak 12 (6%) 
 
Phenotypic synergistic assay vs MALDI-TOF MS 
Twenty-five (12.6%) isolates were dysfunctional by the phenotypic synergistic assay and 12 (6%) 
dysfunctional by MALDI-TOF MS. Ten isolates were dysfunctional by both assays (Table 4.4). Two 
isolates had no peaks and were dysfunctional by MALDI-TOF MS, but functional by the phenotypic 
assay, while 15 were phenotypically dysfunctional but still showed peaks by MALDI-TOF MS (Table 
4.4). Altogether there were 17 isolates with discrepant results after repeating the phenotypic 
synergistic assay for the discrepant isolates. 
 
Table 4.4: Comparison of agr functionality results from the phenotypic synergistic and MALDI-TOF MS 
assays. 
 MALDI-TOF MS 
3005±5WT 3035±5G10S Both peaks No peak/dysfunctional 
Phenotypic 
assay 
Functional 139 2 31 2 
dysfunctional 11 3 1 10 
*The numbers in bold are the number of isolates with discrepant results even after the phenotypic 
assay was repeated. 
 
The prevalence of phenotypic agr dysfunctionality was higher among MRSA isolates (18.5%; 
n=10/54) compared to MSSA isolates (10.3%; n=15/145). In contrast to this, for the MALDI-TOF MS 
assay, agr dysfunctionality was slightly higher among MSSA (6.2%; n=9/145) isolates compared to 
MRSA (5.6%; n=3/54) isolates; however neither result was statistically significant (Table 4.5). 
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Table 4.5: Distribution of agr dysfunctionality among MRSA and MSSA isolates. 
 
Total  
No(%) 
MSSA  
No (%) 
MRSA  
No (%) 
p value* 
Phenotypic 
dysfunction 
25 (12.6) 15 (10.3) 10 (18.5) 0.14 
MALDI-TOF MS 
dysfunction 
12 (6) 9 (6.2) 3 (5.6) 0.71 
*p value <0.05 was interpreted as significant 
 
Correlation between agr type and agr functionality 
The prevalence of agr dysfunctionality was highest among isolates typed as agr type IV (33.3%; 
n=2/6), followed by agr type III (32.4%; n=12/37), II (8.8%; n=5/57) and I (6.1%; n=6/99) using the 
phenotypic test (Table 4.6). However, for the MALDI-TOF MS defined agr dysfunctional isolates, agr 
type III (10.8%; n=4/37) and agr type II (8.8%; n=5/47) showed the highest dysfunctionality rates 
(Table 4.6). Only 3% (n=3/99) of the isolates typed as agr type I were agr dysfunctional by MALDI-
TOF MS. All agr type IV isolates were agr functional with detectable hld peaks by MALDI-TOF MS.  
 
Table 4.6: Proportion of agr types classified as agr dysfunctional by either the phenotypic synergistic 
assay or MALDI-TOF MS. 
 Phenotypic assay MALDI-TOF MS Both assays 
Agr I (n=99) 6 (6.1%) 3 (3%) 2 (2%) 
Agr II (n=57) 5 (8.8%) 5 (8.8%) 5 (8.8%) 
Agr III (n=37) 12 (32.4%) 4 (10.8%) 3 (8.1%) 
Agr IV (n=6) 2 (33.3%) 0 (0%) 0 (0%) 
 
Agr related virulence characteristics of strain types  
For the purpose of this analysis, the agr typing and agr functionality data were combined with the 
spa typing, SCCmec typing and MLST results from Chapter 3, on the neighbour-joining phylogenetic 
tree generated based on spa type, and originally presented as Figure 3.5. 
Twelve spa-CCs were identified of which six consisted of only agr type I isolates (spa-CC 701/2360, 
spa-CC 015/073, spa-CC 032/578, spa-CC NF9, spa-CC NF11, spa-CC NF12), two CCs contained 
only agr type II isolates (spa-CC 002, spa-CC 084), one spa-CC had only agr type III isolates (spa-
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CC 174) and one spa-CC belonged to agr type IV (spa-CC NF10) (Figure 4.6). Two spa-CCs (spa-
CC 012 and spa-CC 5916) were mixed and contained isolates belonging to agr types I and III (Figure 
4.6).  
The dominant strain type among agr type I was t037-ST239-MRSA-IV (n=7) and the most common 
strain types among agr types II and III were t045-ST5/STNT-MRSA-NV/NT (n=22) and t318-ST865 
(n=15) respectively (Table 4.7). 
Of the twenty-five isolates that were dysfunctional by the phenotypic synergistic assay, five were 
t012-MRSA-II (3 MRSA, 2 MSSA), while t045-ST5-MRSA-NV (2 MRSA, 1 MSSA) and t037-ST239-
MRSA-III (3 MRSA) each accounted for three isolates. Two isolates were t399 (2 MSSA) and the 
remaining 12 phenotypically dysfunctional isolates each belonged to a different spa type. Three out 
of the 12 dysfunctional isolates by MALDI-TOF MS were t045-ST5-MRSA-NV (n=3; 2 MRSA, 1 
MSSA). One of the isolates was non-typeable and the remaining 8 each belonged to a different spa 
type (Figure 4.6). 
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Figure 4.6: Phylogeny of the S. aureus isolates based on spa type, with reference to agr type, agr 
functionality, SCCmec type and multi-locus sequence type (MLST, where relevant). The spa typing 
results identified 12 spa-CCs using the BURP algorithm in Ridom StaphType software. The numbers on the 
end on each branch represent the strain’s  spa type and the spa-CC. The strains in blue are agr type I, black 
are agr type II, green belongs to agr type III and red agr type IV. The strains in bold are MRSA isolates while 
the highlighted strains represent isolates selected for MLST. “DYSF” indicates isolates with a dysfunctional 
agr locus based on both assays. 
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Table 4.7: Agr type assignment for the dominant strain types as described by spa typing, MLST and 
SCCmec typing. 
Agr type Dominant strain types (n) MSSA/MRSA/Mixed 
Agr type I t037-ST239-MRSA-IV (7) MRSA 
t032-ST22-MRSA-IV (7) MRSA 
t1257-MRSA-IV (5) MRSA 
t015-ST508 (5) MSSA 
t701 (5) MSSA 
t355 (9) MSSA 
t1476-ST8 (7) 6 MSSA, 1 MRSA 
Agr type II t045-ST5/STNT-MRSA-NV/NT (22) 2 MSSA, 20 MRSA 
t002-ST5 (13) MSSA 
t084-ST15 (5) MSSA 
Agr type III t318-ST865 (15) 14 MSSA, 1 MRSA 
t012-ST36-MRSA-II (7) 3 MSSA, 4 MRSA 
 
Discussion 
In the present study, the agr types of 199 S. aureus isolates obtained from patients with bacteraemia 
at Tygerberg Hospital were determined. Agr type I is reportedly the most prevalent among clinical 
isolates and agr type IV represents the minority of strains isolated (Traber et al., 2008). Similarly in 
our study the dominant agr type was agr type I, followed by agr type II, III and IV. This is consistent 
with studies from the United States and the United Kingdom which also report agr type I as the 
dominant type followed by agr type II, III and IV (Moore and Lindsay, 2001; Traber et al., 2008; 
Schweizer et al., 2011). However, this pattern differed in some other studies. For example; a study 
performed in Spain reported the dominant agr type to be II, followed by I, III and IV (Vindel et al., 
2009). Another from France reported agr type I as the dominant type, but this was followed by II, IV 
and III (Jarraud et al., 2002). In the United States two studies reported agr type I followed by agr 
type III, II and IV (Shopsin et al., 2003; Wright et al., 2005).  
This difference in dominant agr types could be explained by the difference in dominant strain types 
circulating in that setting. Also, the type of clinical infection from which S. aureus was identified might 
explain these differences, since certain agr types have been shown to be associated with specific 
types of infections (Robinson et al., 2005). Identical strain types and those closely related to each 
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other have been shown, in most cases, to fall within the same agr type. Therefore, dissimilarities in 
local dominant strain types, outbreaks as well as study design could account for the widely varying 
distributions of agr types (Dufour et al., 2002; Shopsin et al., 2003; Traber et al., 2008). This can be 
seen in a study performed on CA-MRSA isolates in Egypt where agr type III and IV were the only 
reported types (Enany et al., 2010). Furthermore, the dominant strains in the Egyptian study were 
identified as ST30 and ST80 which are associated with agr type III, explaining the dominance of this 
type (Ramdani-bouguessa et al., 2006; Enany et al., 2010; Breurec et al., 2011). Agr type III strains 
are also known to be associated with CA-MRSA which further explains agr type III dominance of agr 
type III in this Egyptian study, which only investigated CA-MRSA (Robinson et al., 2005).  
Two previous studies done at Tygerberg Hospital have also performed agr typing on S. aureus 
isolates; one from clinical specimens other than blood cultures (2009) and another from blood 
cultures and nasal swabs of the same patient (2010-2012) (Oosthuysen et al., 2013; Karayem, 
2014). Agr type distributions similar to ours were reported by all three studies done in this setting. In 
all three studies, agr type I was dominant among MSSA and MRSA isolates, however, agr type II 
was the second most prevalent in the 2010-2012 study as oppose to type III amongst MSSA isolates 
in the 2009 study (Oosthuysen et al., 2013; Karayem, 2014). This difference may be attributed to the 
difference in dominant strain among the MSSA isolates, which was t891 and agr type III, causing a 
higher prevalence of agr type III in among these isolates (Oosthuysen et al., 2013). An association 
between agr type I and invasive infections, especially bacteraemia, has previously been described, 
while agr type III was linked to non-invasive infections (Ben Ayed et al., 2006). This further explains 
the higher prevalence of agr type III in the 2009 study, since all clinical sources apart from blood 
culture were included. Agr type IV was the least common agr type present among MSSA and MRSA 
isolates for this study as well as the 2009 collection, while no agr type IV isolates were detected 
among isolates collected in the 2010-2012 study.  
Ten of the twelve spa-CCs identified in this study contained isolates of only one agr type (Figure 
4.6). spa-CC 012 and spa-CC 5916, however, contain isolates belonging to agr type III and agr type 
I, suggesting that recombination of agr could have occurred. Two models have been proposed for 
the evolution of agr and strain types (Wright et al., 2005; Robinson et al., 2005). The first, by Wright 
et al. (2005), suggests that the divergence of agr types preceded the development of mutations that 
are currently used to distinguish between strains and states that strains are phylogenetically 
structured according to agr type. This hypothesis is based on the observation that related or 
corresponding strain types (typed by any strain typing method) were present in only one agr type. 
Wright et al. (2005) noted that a megabase separates the spa, multi-locus sequence typing (MLST), 
coa and SCCmec loci from the agr locus and speculated that recombination between strains could 
affect these loci while leaving the agr locus intact. However, a few cases have been reported where 
strains from a single lineage or CC have different agr types due to intrastrain rearrangements and 
interstrain recombination (Wright et al. 2005; Robinson et al. 2005), and this is not accounted for by 
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the Wright model. Robinson et al. (2005) refuted the first hypothesis and suggested that 
recombination of the agr locus between CCs could result in more than one agr type being present 
within a CC (Robinson et al., 2005). Genetically identical strains as well as CCs are expected to 
have the same agr type since variations in housekeeping genes occur approximately 15 times more 
often by mutations than by recombination. Therefore, because of these exceptions, Robinson et al. 
(2005) presented a model that takes this recombination into account, making it the more acceptable 
model. They also reported that agr type I and III strains could cluster together, based on visual 
inspection of phylogenetic trees generated from nucleotide sequences of the hypervariable region 
of the agr locus (agrB, agrD and agrC) (Robinson et al. 2005). This could result in novel, 
advantageous patterns of agr-mediated gene expression causing different disease presentations 
within a CC (Robinson et al., 2005). Our results are consistent with the model described by Robinson 
et al. (2005). The relationship between agr type and various clinical features and outcome are 
interrogated in chapter 5. 
Of the 199 isolates, 25 (12.5%) were classified as agr dysfunctional by the phenotypic synergistic 
assay, which is lower than previously reported at Tygerberg Hospital, using the same method. 
Karayem (2014) investigated agr functionality amongst isolates from blood cultures and nasal swabs 
and documented 29.3% of the isolates collected as agr dysfunctional (Karayem 2014). This previous 
study investigated nasal and blood samples of which 79% of isolates where pairs and 57.4% of all 
bacteraemia cases were endogenous (same strain in nasal and bacteraemia). The difference in agr 
dysfunctionality between this and Karayem’s (2014) study is not likely due to the difference in clinical 
samples used since agr dysfunctionality rates among blood cultures and nasal swabs has previously 
been reported to be similar (Smyth et al., 2012). The difference in the prevalence of agr 
dysfunctionality may be attributed to the subjectivity of the phenotypic synergistic test; what one 
reader may call dysfunctional may be called functional or weak functional by another. In our study 
we tried to overcome this by repeating the phenotypic synergistic test for all isolates in triplicate and 
having three people read the results. Where discrepancies were identified the phenotypic synergistic 
test was repeated.  
Other studies investigating agr dysfunctionality, from multiple infection sites, using the phenotypic 
synergistic assay have reported agr dysfunctionality rates of 9% (Sakoulas et al., 2009), 13% 
(Ferreira et al., 2013), 15% (Tsuji et al., 2011) and 22% (Schweizer et al., 2011); which are more 
comparable with the findings of this study. Thirteen (6.5%) isolates were dysfunctional by MALDI-
TOF MS compared to the 10.1% dysfunctional isolates described in the study performed by Gagnaire 
et al. 2012.  
Agr dysfunctionality has been described to be associated with MRSA strains (Sakoulas et al., 2009), 
however this was not the case in our study. Although not statistically significant, agr functionality was 
slightly higher among MRSA isolates compared to MSSA isolates using the phenotypic synergistic 
assay; but lower using MALDI-TOF MS. In addition, there was no association between agr 
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dysfunctionality and any specific spa type. The 25 agr dysfunctional isolates belonged to 16 different 
spa types and seven different spa-CC; and two dysfunctional isolates were singletons. Therefore, 
dysfunctionality of the agr locus was not clone specific, which is in agreement with results from 
Shopsin et al. (2008). In contrast to this, agr dysfunction has previously been reported to be 
significantly associated with CC8  and CC30 (Holmes et al., 2014). 
In this study, both the phenotypic synergistic assay and MALDI-TOF MS were used to determine agr 
functionality. The results of the two methods were comparable with results previously reported by 
Gagnaire et al. (2012), who reported a 100% concordance between the results of the two tests. In 
our study 171 isolates were functional by both methods and 10 were dysfunctional by both, thus 181 
isolates had the same result from both methods representing a correlation of 91% between the two 
tests. There were, however, some discrepant results between the two tests. 
Fifteen isolates were identified which showed no -haemolysis on sheep blood agar, but had a -
haemolysin peak on MALDI-TOF, while thirty-two isolates reported as functional by MALDI-TOF MS 
had both the wild type and variant δ-haemolysin peak (1 dysfunctional and 31 functional by the 
synergistic assay). A previous study reported cases where different haemolysis patterns were 
observed in isolates from the same specimen; both agr functional and dysfunctional isolates were 
present in the same patient (Traber et al., 2008). The isolates where shown to be the same strain 
type. Since the isolates were obtained directly from the infected material, the authors believed that 
the difference in the -haemolysis patterns was not because of post-isolation loss of activity, but 
rather from a mixed strain population in the patient (Traber et al., 2008). This might in part explain 
the cases where both the wild type δ-haemolysin peak as well as the variant δ-haemolysin peak 
were observed, since separate colonies with different agr functionalities from the already mixed 
population might have been used during these tests. This can be investigated by sequencing the 
gene encoding -haemolysin from multiple colonies from the isolates to confirm whether both wild 
type and the variant are present.  
Three of the agr functional isolates identified by the phenotypic synergistic assay did not have a 
detectable -haemolysin peak on MALDI-TOF MS. It has been reported that synergistic haemolysis 
with the -haemolytic strain RN4220 is not exclusively due to -haemolysin, but that a series of 
phenol soluble modulins (PSMS), produced in almost all S. aureus strains, also show synergistic 
haemolysis capabilities on sheep blood agar (Cheung et al., 1994). The study concluded that the 
phenotypic synergistic assay should not be used for detecting the presence of -haemolysin, but it 
is still reliable for determining whether the agr locus is functional since all PSMs are controlled by 
the agr locus (Cheung et al., 1994). This could explain why some isolates from our study have no -
haemolysin peak by MALDI-TOF MS, but still indicate haemolysis on sheep blood. It could also be 
speculated that there are variants, other than the G10S variant, resulting in the production of a 
protein that is not represented by the known peak sizes currently described and was therefore not 
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screened for when looking at peaks by MALDI-TOF MS. To confirm this, further investigation is 
required. Further research may include sequencing of the agr locus, specifically agrA, B, C and D, 
to identify whether there are mutations, other than the ones already described, responsible for agr 
dysfunctionality. The gene encoding -haemolysin can be sequenced to determine whether there 
are alternative mutations resulting in a different MALDI-TOF MS peak that was not detected. 
Investigation of the expression levels of the agr effector molecule RNAIII may also be used to further 
investigate agr functionality. 
Conclusion 
In conclusion, this chapter describes the prevalence of the four different agr types and agr 
dysfunctionality amongst the S. aureus strains isolated from blood cultures from patients at 
Tygerberg Hospital. Agr type I was the most common agr type and there was no significant difference 
in the distribution of agr types in MRSA and MSSA isolates. The dominant strain in this study was 
agr type II (t045-ST5-MRSA-NV) especially among MRSA isolates. The most prevalent strain type 
among MSSA isolates was agr type III (t318-ST1865). Two assays were used to determine the rate 
of agr dysfunctionality among the isolates and the results of the two assays were, for the most part, 
comparable; however, some discrepancies were identified. Agr dysfunctionality was not common in 
this study and it was not significantly different between MRSA and MSSA isolates. Agr 
dysfunctionality was not associated with any  specific clone. This study provides the basis for further 
studies that aim to determine the effects of agr type and agr functionality/dysfunctionality on S. 
aureus virulence and clinical disease (Chapter 5). 
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 The impact of strain characteristics on disease presentation and clinical 
outcome 
Introduction  
Staphylococcus aureus is an opportunistic and highly virulent pathogen, able to cause life-
threatening infections. Many clinical settings are dedicating a substantial amount of resources to 
screen for methicillin-resistance (through mecA gene detection) to ultimately improve patient 
outcome, since an association between increased mortality and methicillin-resistant S. aureus 
(MRSA) isolates, especially in the context of bacteraemia, has been described (Cosgrove et al., 
2003; Schweizer et al., 2011). There are, however, other microbiological characteristics that may be 
equally important to detect in the pursuit to improve patient outcome. 
Certain strain types and agr related virulence characteristics may be predictors or risk factors for 
clinical outcomes such as mortality and increased length of stay. Agr dysfunctional strains, for 
example, have been linked to persistent bacteraemia, reduced susceptibility to vancomycin as well 
as an increased mortality (Fowler, Jr. et al., 2004; Sakoulas et al., 2005; Schweizer et al., 2011). 
Therefore, S. aureus strain typing and virulence profiling are essential to track and reduce the spread 
of infection (Earls et al., 2017).  
Determining the exact role of the genetic background and virulence profile of S. aureus isolates on 
patient outcome has become challenging because of the host specificity of virulence profiles as well 
as the high diversity of these isolates (Pérez-Montarelo et al., 2018). Because of these difficulties, 
data comparing strain types and agr related virulence characteristics with clinical outcome and 
disease presentation in our setting are limited. Insight into this may provide progress in treatment of 
staphylococcal disease. The purpose of this chapter was to assess associations between strain 
types and agr related virulence characteristics and clinical presentation and patient outcome.  
Methodology 
This study included 199 patients of all ages with S. aureus bacteraemia at Tygerberg Hospital 
between January 2015 and March 2017, from whom non-duplicate S. aureus isolates were collected, 
as described in Chapter 2. Clinical and demographical data were documented by the Group for 
Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA). Isolates 
were classified as MRSA using the Vitek®2 system (bioMérieux, France).  
Logistic regression models for categorical variables were used to assess associations between the 
final outcomes, mortality and methicillin resistance; and  various patient- and isolate-related 
variables, using both univariable and multivariable analyses. The variables included were age group, 
gender, diagnosis, place of onset of infection (HA, HCA and CA) (Chapter 2), spa-CC (Chapter 3), 
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and agr type and agr functionality (Chapter 4). For the purpose of this analysis, the spa-CCs were 
grouped into five groups, namely, spa-CC002, spa-CC012, spa-CC701/2360, singletons and other 
(spa-CC 015/037, spa-CC 084, spa-CC 032/578, spa-CC 174, spa-CC 5916, spa-CC NF9, spa-CC 
NF10, spa-CC NF11 and spa-CC NF12). In the multivariable analysis, stepwise elimination was 
done for all variables with p-values of <0.1. Length of stay was analysed as a continuous variable; 
therefore, the two-sample Wilcoxon rank-sum (Mann-Whitney) test and survival analysis were used 
for univariable and multivariable analysis, respectively. In the survival analysis, the final outcome 
was length of stay and discharge was used as the failure event. Statistical analysis was done on 
Stata V15 (StataCorp LLC, USA) and p-values of <0.05 were interpreted as significant.  
Results 
Mortality 
The univariable analysis showed an association between age group and mortality, with a significant 
increase in mortality in the elderly age group compared to neonates (p=0.007) (Table 5.1). This was 
confirmed by the multivariable analysis which showed a significant increase in mortality in adults 
(OR=2.28; 95% CI: 0.92 – 5.62; p=0.073) and elderly patients (OR=7.48; 95% CI: 2.82 – 19.89; 
p<0.001), in comparison to neonates (Figure 5.1). No significant associations between mortality and 
gender, diagnosis, place of onset of infection, spa-CC, and agr type or dysfunctionality were 
identified in the univariable analysis (Table 5.1). However, HA infections were associated with higher 
mortality compared to CA infections, based on the multivariable analysis (OR= 2.26; 95% CI: 1.12 – 
4.55; p=0.023). 
MRSA 
There is an association between MRSA infection and age based on the univariable analysis, with 
neonates being more likely to have an MRSA infection than other age groups (Table 5.1). This was 
however not the case in the multivariable analysis, where there was no significant association 
between MRSA and age (Figure 5.1). MRSA was associated with HA infections in both the 
univariable and multivariable analyses (Table 5.1, Figure 5.1). spa-CC 002 was associated with 
MRSA in both analyses, with a lower MRSA prevalence amongst the singletons and spa-CCs 
grouped as “other” (Table 5.1, Figure 5.1). There were no associations between MRSA and gender, 
diagnosis, agr type or dysfunctionality. 
Length of stay 
There were significant associations between length of stay and age, place of onset of infection, spa-
CC and agr types, based on the univariable analysis (Table 5.1). However, for the multivariable 
analysis, only place of onset of infection was significantly associated with the length of stay (Figure 
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5.1). HA infections were associated with a shorter length of stay compared to CA infections 
(OR=0.48; 95% CI: 0.30 – 0.76; p=0.002), while HCA infections are associated with an increased 
length of stay (OR=1.97; 95% CI: 1.13 – 3.42; p=0.017). There was no significant association 
between length of stay and agr functionality in the univariable analysis. However, a borderline 
significant association between agr functionality and an increased length of stay was identified in the 
multivariable analysis (OR=1.66; 95% CI: 0.93 – 2.99; p=0.089) (Figure 5.1). There were no 
associations between length of stay and gender or diagnosis in either the univariable or multivariable 
analysis. 
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Table 5.1: Univariable analysis of age group, gender, diagnosis, place of onset of infection, strain type, agr type and functionality with mortality, MRSA infections 
and length of stay. 
Variable 
Clinical outcome 
Mortality MRSA Length of stay 
OR 95% CI p-value OR 95% CI p-value p-value 
Age group       0.002 
 Neonates - - - - - - - 
 Children 0.98 0.24 – 4.00 0.978 0.25 0.08 – 0.81 0.021 - 
 Adults 2.55 0.80 – 8.17 0.115 0.26 0.10 – 0.70 0.008 - 
 Elderly 5.41 1.59 – 18.39 0.007 0.16 0.05 – 0.51 0.002 - 
Gender       0.901 
 Male compared to Female 1.12 0.61 – 2.04 0.717 0.62 0.33 – 1.18 0.145 - 
Diagnosis       0.169 
 Bacteraemia without focus compared to with focus 1.76 0.87 – 3.55 0.114 1.81 0.85 – 3.87 0.124 - 
Place of onset of infection       <0.001 
 CA - - - - - - - 
 HA 1.28 0.59 – 2.77 0.530 12.83 2.94 – 56.09 0.001 - 
 HCA 0.71 0.27 – 1.80 0.466 3.32 0.65 – 17.03 0.150 - 
spa-CC       0.045 
 spa-CC002 - - - - - - - 
 spa-CC012 1.11 0.44 – 2.84 0.821 0.68 0.27 – 1.71 0.413 - 
 spa-CC701/2360 1.65 0.59 – 4.64 0.342 0.48 0.16 – 1.41 0.182 - 
 Singletons 0.94 0.36 – 2.47 0.905 0.07 0.02 – 0.35 0.001 - 
 Other spa-CCs 0.98 0.44 – 2.19 0.964 0.24 0.10 – 0.56 0.001 - 
agr type       0.044 
 I - - - - - - - 
 II 0.73 0.37 – 1.44 0.368 1.44 0.72 – 2.91 0.307 - 
 III 0.50 0.22 – 1.15 0.103 0.62 0.24 – 1.58 0.319 - 
 IV 0.68 0.12 – 3.88 0.663 1.00 - - - 
Phenotypic synergistic agr assay       0.451 
 Functional compared to dysfunctional 0.72 0.31 – 1.67 0.452 0.51 0.21 – 1.21 0.127 - 
*OR – Odds Ratio, CI – Confidence Interval, HR – Hazards Ratio, Other spa-CC – spa-CC 015/037, spa-CC 084, spa-CC 032/578, spa-CC 174, spa-CC 5916, spa-
CC NF9, spa-CC NF10, spa-CC NF11, spa-CC NF12. The statistically significant results are highlighted in bold. 
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Figure 5.1: Independent risk factors for the clinical outcomes mortality, MRSA infection and length of stay presented in forest plot form, following the multivariable 
analysis. Variables associated with mortality were highlighted in blue, while variables associated with MRSA infections are in green. Black are those associated with length of 
stay when the variable “discharged” is considered as failure for the survival analysis. Mortality and MRSA infection results were reported as odds ratio, and length of stay was 
reported as hazards ratio. 
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Odds Ratio / Hazards Ratio
Adults vs Neonates (OR=2.28; 95% CI: 0.92 – 5.62; p=0.073)
Elderly vs Neonates (OR=7.48; 95% CI: 2.82 – 19.89; p<0.001)
HA vs CA (OR= 2.26; 95% CI: 1.12 – 4.55; p=0.023)
HA vs CA (OR=4.77; 95% CI: 2.09 – 10.87; p<0.001)
Singletons vs spa-CC002 (OR= 0.12; 95% CI: 0.03 – 0.57; p=0.007)
Other spa-CC vs spa-CC002 (OR=0.36; 95% CI: 0.16 – 0.79; p=0.011)
HA vs CA (HR=0.48; 95% CI: 0.30 – 0.76; p=0.002)
HCA vs CA (HR=1.97; 95% CI: 1.13 – 3.42; p=0.017)
Functional vs Dysfunctional (HR=1.66; 95% CI: 0.93 – 2.99; p=0.089)
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Discussion 
Complicated bloodstream infections caused by S. aureus are difficult to treat and have a mortality 
rate ranging from 29-63% (Perovic et al., 2015). Specific host and pathogen factors are known to 
predict poor outcomes and less effective response to vancomycin (Schweizer et al., 2011). This 
chapter discusses possible associations between strain characteristics (strain type and agr related 
virulence) and clinical presentation and patient outcome.  
In our study, older age was shown to be a risk factor for mortality. This is inconsistent with a previous 
study performed on S. aureus bacteraemia isolates from patients in Johannesburg, which found no 
association between older age and mortality (Perovic et al., 2006). This difference may be attributed 
to the difference in the definition of age groups and mortality; in our study crude in-hospital mortality 
was used, whereas the Perovic study used 14-day mortality and also reported a low median age. 
However, our results are consistent with a previous study performed in Gauteng and the Western 
Cape, which compared HA-MRSA and CA-MRSA with crude in hospital mortality data collected by 
GERMS-SA (Perovic et al., 2017); and increased mortality (within 12 weeks of first blood culture) 
among elderly patients was also reported by a study performed in the USA (McClelland et al., 1999). 
Interestingly, they also reported that elderly patients were three times more likely to not present with 
a fever prior to diagnosis, which may have resulted in a delayed diagnosis and treatment. Other 
studies have reported that poor outcomes in bacteraemia are related to delays in starting treatment 
with the correct antibiotics (McClelland et al., 1999). The increased mortality among elderly patients 
may also be attributed to the fact that older patients have a higher risk of HA infections because of 
immunosenescence, impaired wound healing and multiple comorbidities (McGarry et al., 2004). In 
this study, HA infections were also associated with an increased mortality, which further explains the 
association between age and mortality.  
Another factor that may contribute to poorer outcomes in elderly patients is the commonly described 
association between elderly patients and MRSA infections (Soriano et al., 2000; McGarry et al., 
2004; Cosgrove et al., 2005; Struelens et al., 2009). This was however not the case in our study. 
Elderly patients were less likely to have MRSA infections, based on the univariable analysis, but this 
association was not confirmed in the multivariable analysis. The MRSA outbreak in the paediatric 
and neonatal wards during 2015 and 2016 may have influenced this result.  
HA infections were associated with all three outcomes namely, mortality, MRSA infection and length 
of stay. The association between HA infections and MRSA is not surprising since the antibiotic 
selective pressure is higher in hospitals than in the community. Isolates that have acquired mobile 
genetic elements that offer advantages are selected for in hospitals resulting in a higher MRSA 
prevalence in hospitals compared to the community (Stefani et al., 2012). The association between 
HA infections and an increased mortality may be linked to the association between HA infections 
and MRSA, since previous studies, performed in different settings, have reported higher mortality 
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due to the complications associated with MRSA bacteraemia compared to MSSA bacteraemia 
(Soriano et al., 2000; Topeli et al., 2000; Cosgrove et al., 2003; Perovic et al., 2006). Although there 
was no significant difference in mortality between MRSA and MSSA infections in this study, a meta-
analysis performed on 31 studies comparing mortality in patients with MRSA infections to MSSA 
infections reported an overall increase in mortality among patients with MRSA infections. 
Interestingly, this association reached significance only in 7 out of the 31 studies included in the 
meta-analysis, the reason being that many of the studies were small and didn’t have power to detect 
significant associations. However, the pooled analysis showed an apparent  association between 
increased mortality and MRSA infections (Cosgrove et al., 2003).  
HA infections were also associated with a shorter length of stay. This is inconsistent with a previous 
study which investigated the effects of S. aureus bacteraemia on patient outcomes. The study 
reported increased length of stay among patients with HA infections (Cosgrove et al., 2005). The 
paradoxical reduction in length of stay among patients with HA infections observed in this study may 
be due to the paediatric and neonatal MRSA outbreak which may have resulted in cases of less 
complicated bacteraemia amongst neonates, which would have “resolved” more rapidly than 
complicated S. aureus bacteraemia.  
Our molecular epidemiology results (Chapter 3) suggest a high diversity among S. aureus strains 
causing bacteraemia in our setting. However, there was a noteworthy difference in clonality between 
MRSA and MSSA, with MSSA isolates being more genetically diverse, which is consistent with 
previous studies performed in the USA and Europe (Miko et al., 2013; Grundmann et al., 2014; Park 
et al., 2017; Pérez-Montarelo et al., 2018). CC5 was the most prevalent lineage among MRSA 
strains, accounting for 64% of the MRSA strains, with more than half of these belonging to spa-
CC002. spa-CC 002 (CC5) was identified as a risk factor of MRSA infections. It is worth noting that 
the outbreak strain (t045) which forms part of spa-CC 002, represented the majority of the MRSA 
strains, possibly contributing to this association. A recent study performed in Spain, also reported a 
significant association between CC5 and MRSA infections, while CC30, CC45 and CC15 were 
associated with MSSA infections (Pérez-Montarelo et al., 2018). Although we cannot report a direct 
association between CC30, CC45 and CC15 with MSSA isolates, these CCs were present among 
the singletons and the spa-CCs grouped in “other”, which were negatively associated with MRSA.  
The agr locus is known to be involved in the regulation of 23 virulence genes (George and Muir, 
2007). This observation has led to the assumption that the agr locus is important in staphylococcal 
pathogenesis (Kong et al., 2006). However, there are many studies with contradicting results 
regarding the importance of a functional agr locus in staphylococcal pathogenesis. Our multivariable 
analysis identified a borderline significant association between agr functionality and increased length 
of stay, while there were no associations between agr functionality and mortality or MRSA infections. 
However, the number of dysfunctional isolates in our study is very small, which may have affected 
our ability to detect significant differences. within contrast to our results, a study performed in the 
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USA reported significantly increased mortality among bacteraemia patients infected with agr 
dysfunctional strains (Schweizer et al., 2011). The study reported a high prevalence of MRSA 
infections and therefore a large proportion (86%) of the patients were treated with vancomycin. 
According to pharmacodynamic models, vancomycin has reduced bactericidal activity against agr 
dysfunctional strains (Sakoulas et al., 2005), therefore it was concluded that the association between 
agr dysfunction and mortality may have been linked to the reduced bactericidal activity of 
vancomycin against agr dysfunctional strains (Schweizer et al., 2011). While our results suggest a 
shorter length of stay among patients infected with agr dysfunctional strains, other studies have 
reported associations between agr dysfunctionality and persistent bacteraemia, which could result 
in an increase in hospital stay (Fowler, Jr. et al., 2004; Chong et al., 2013).  
There was also no significant association between agr dysfunction and MRSA infections in our study, 
which is contradictory to previous studies which reported a high prevalence of agr dysfunctionality 
among MRSA isolates (Gagnaire et al., 2012; Jang et al., 2012). Agr dysfunctionality has previously 
been described to be less prevalent among SCCmec IV isolates compared to SCCmec I-III (Jang et 
al., 2012). SCCmec IV was the dominant SCCmec type present among our MRSA isolates, which 
might account for the lower prevalence of agr dysfunction in our study, and may explain why no 
association between agr dysfunction and MRSA was identified. 
A limitation to this study is that many patients had incomplete or missing data profiles, especially 
with regards to the focus of the bacteraemia. The diagnosis assigned to the majority of the patients 
was bacteraemia without focus, however it is possible that the focus of the bacteraemia was 
unknown at the time of data collection by the GERMS-SA surveillance officer or that thorough 
investigation of the focus was not done; and this may have overestimated the number of patients 
with this diagnosis. In a previous study, bacteraemia with respiratory infection as the focus was 
associated with MRSA and increased mortality, while bacteraemia as a result of skin and soft tissue 
infections was associated with a lower mortality and a shorter length of stay (Cosgrove et al., 2005). 
Different agr types have also been associated with certain disease types, such as agr types I and II 
with endocarditis (Jarraud et al., 2002). We were unable to investigate similar associations, since 
the majority of the patients included in our study were diagnosed with bacteraemia without focus.  
Conclusion 
This section investigated associations between strain types and agr related virulence characteristics 
identified in Chapters 3 and 4 and the clinical outcomes and presentations described in Chapter 2. 
Adults and elderly patients were at higher risk for mortality, which is consistent with previous studies. 
HA infections were associated with MRSA, higher mortality as well shorter length of stay.. A 
previously described association between spa-CC 002 (CC5) and MRSA was also identified in our 
setting, however, this association may have been driven by an outbreak since spa-CC 002 included 
the outbreak strain t045. Identifying associations between strain characteristics and clinical data may 
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lead to a better understanding of how different strain types and the agr regulator contribute to S. 
aureus virulence; and may ultimately aid in the development of alternative treatment plans or 
prevention of staphylococcal disease. 
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 Concluding remarks 
This study sought to describe the molecular epidemiology of S. aureus isolates identified from 
bacteraemic patients at Tygerberg Hospital, and to investigate the possible associations between 
microbial characteristics and clinical outcome and presentation. In South Africa, data describing the 
link between epidemiology and virulence characteristics, and clinical outcome are limited. Therefore, 
our study may provide a baseline overview for future investigations.  
We noted that MRSA accounted for 27% of the 199 S. aureus isolates included in this study, which 
was lower than the 33% and 24% documented in 2015 and 2017 respectively in Gauteng and the 
Western Cape by GERMS-SA (Crowther-Gibson & Quan 2016; Crowther-Gibson & Quan 2017). 
Spa typing data suggested a highly diverse S. aureus population circulating within Tygerberg 
Hospital, this is reflected by the 73 different spa types identified. This genetic diversity was driven by 
MSSA strains, since MRSA strains were more clonal; which is consistent with literature (Miko et al., 
2013; Grundmann et al., 2014; Park et al., 2017; Pérez-Montarelo et al., 2018). Both locally emerged 
and pandemic clones were identified in this study; t045-ST5-MRSA-NV (novel variant) was the most 
dominant MRSA clone and it seems to be circulating in hospital settings within South Africa as shown 
by previous studies. This clone was associated with a paediatric and neonatal outbreak at Tygerberg 
Hospital in 2015 and 2016. t1257-ST612-MRSA-IV is also a local dominant clone which also seems 
to be well adapted to health care settings nationwide. Pandemic clones such as t037-ST239-MRSA-
III, t032-ST22-MRSA-IV and t012-ST36-MRSA-II were also identified in this study. Statistical 
analysis showed that MRSA strains were associated with hospital acquired (HA) infections, which is 
not surprising considering antibiotic selective pressure is higher in hospitals compared to the 
community and spread of resistant strains in hospitals is common (Stefani et al., 2012). 
The overall crude mortality rate was 29% and older patients were found to be the most affected. This 
is in agreement with previous studies (McClelland et al., 1999; Perovic et al., 2017). Mortality was 
also associated with HA infections, which could be explained by the complicated nature of these 
infections leading to death (Soriano et al., 2000; Topeli et al., 2000; Cosgrove et al., 2003; Perovic 
et al., 2006). 
Agr typing revealed that agr type I was the most common type and there was no significant difference 
in the distribution between MSSA and MRSA isolates. We compared the agr functionality of the 
included isolates using two assays, the phenotypic synergistic assay and matrix assisted laser 
desorption ionization time of flight mass spectrometry (MALDI-TOF MS). This was done due to 
subjectivity linked to the phenotypic synergistic assay. However, the findings from these assays were 
comparable, with limited discrepancies. The discrepancies may be due to the fact  that phenol 
soluble modulins (PSMs), which are also controlled by the agr locus, can also result in synergistic 
haemolysis with the -haemolytic strain RN4220 on sheep blood agar (Cheung et al., 1994). 
Therefore, the phenotypic synergistic assay investigates crude activation of the agr locus, while 
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MALDI-TOF MS investigates only the presence of -haemolysin. Nevertheless, the phenotypic assay 
identified 12.6% dysfunctional isolates as opposed to 6% identified by MALDI-TOF MS. Overall, this 
dysfunctionality rate was low and did not show any clonal preference, in keeping with results from 
Shopsin et al. (2008); whereas some studies have shown that agr dysfunctionality was linked with 
CC8 and CC30 (Holmes et al., 2014). The association between agr functionality status and clinical 
outcome is controversial. We observed a trend towards a significant association between agr 
dysfunctionality and a shorter length of hospital stay, however the number of dysfunctional strains in 
this study is small and ascertaining the reason for this association would require further investigation. 
There were no associations between patient diagnosis and mortality, MRSA or length of stay. This 
may be because majority of the patient diagnoses were documented as bacteraemia without focus; 
possibly because a thorough investigation of the focus was not done or the focus of the bacteraemia 
was unknown at the time of collection by the GERMS-SA surveillance officer.  
This study provided insights into the associations between microbial characteristics and clinical 
outcome despite the limited clinical data used. This should be overcome in planning future studies. 
Future directions may include investigating additional associations between agr-related virulence 
factors and clinical features such as treatment, severity of illness or diagnosis. Different disease 
types have been associated with different outcomes; for example respiratory infections are 
associated with increased mortality, while skin and soft tissue infections have a lower mortality 
(Cosgrove et al., 2005). Therefore, this study could be extended to isolates from all clinical 
specimens, to allow the identification of associations between the type of infection and outcome, as 
well as agr type, agr functionality and strain type. Further research may also include sequencing of 
the agr locus to identify possible mutations responsible for agr dysfunctionality, and reverse 
transcription quantitative PCR to investigate RNAIII expression; to further investigate discrepancies 
between the phenotypic synergistic assay and MALDI-TOF MS. Furthermore, experiments to 
describe the effect of agr dysfunction on the physiology of S. aureus isolates may also provide insight 
into disease presentation among agr dysfunctional strains. Altogether these investigations could add 
to the understanding of specific agr-related virulence profiles and may ultimately improve patient 
outcome.  
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